Sogen Data · Datasets · 数据专题
肺动脉高压数据集锦
单细胞 · 空转 · bulk 转录组
本专题承自 Sogen Data 数据整理体系,逐条人工复核,附研究设计、样本量、平台与 GEO/PubMed 直达链接。
人源单细胞
Human · Single-cell
-
01 GSE244781 对系统性硬化症合并肺动脉高压(SSc-PH)患者、特发性肺动脉高压(iPAH)患者及健康对照的肺组织进行单细胞RNA测序,比较各组间血管细胞的转录组差异。SSc-PH组(n=16)、iPAH组(n=3)和健康对照组(n=15)样本均经Collagenase A/DNase I或Liberase DL/DNase I消化处理,部分样本通过磁珠分选耗尽特定细胞群体。
设计对系统性硬化症合并肺动脉高压(SSc-PH)患者、特发性肺动脉高压(iPAH)患者及健康对照的肺组织进行单细胞RNA测序,比较各组间血管细胞的转录组差异。SSc-PH组(n=16)、iPAH组(n=3)和健康对照组(n=15)样本均经Collagenase A/DNase I或Liberase DL/DNase I消化处理,部分样本通过磁珠分选耗尽特定细胞群体。
摘要Pulmonary hypertension (PH) is a common complication of systemic sclerosis (SSc) and a leading cause of mortality among patients with this disease. PH can also occur as an idiopathic condition (idiopathic pulmonary arterial hypertension, iPAH). We sought to investigate the transcriptomic alterations in PH vascular populations to understand cellular mechanisms underlying pathobiology of systemic sclerosis associated and idiopathic pulmonary hypertension.
-
02 GSE293580 对人类肺组织样本进行单细胞 RNA 测序,比较系统性硬化症相关肺动脉高压(SSc-PAH)与特发性肺动脉高压(IPAH)患者的基因表达差异,并与失败供体样本作为健康对照进行比较。SSc-PAH、IPAH 和失败供体各包含 4 个独立样本,采用标准化协议获取肺移植时的组织样本,经冠状切片处理后提取单细胞进行测序。
设计对人类肺组织样本进行单细胞 RNA 测序,比较系统性硬化症相关肺动脉高压(SSc-PAH)与特发性肺动脉高压(IPAH)患者的基因表达差异,并与失败供体样本作为健康对照进行比较。SSc-PAH、IPAH 和失败供体各包含 4 个独立样本,采用标准化协议获取肺移植时的组织样本,经冠状切片处理后提取单细胞进行测序。
摘要Pulmonary arterial hypertension (PAH) is characterized by progressive cellular and molecular changes within the pulmonary vasculature that lead to structural remodeling, rising pulmonary vascular resistance and, if untreated, right ventricular failure. In clinical practice, PAH treatments have evolved little over the last two decades, and until recently, all approved therapies have targeted one of three molecular pathways: the nitric oxide (NO) signaling pathway, the endothelin pathway, or the prostacyclin pathway. With these therapies, treatment responses have been modest and variable, with patients experiencing a heterogeneity of treatment effects. In particular, patients with PAH related to systemic sclerosis (SSc-PAH) have derived less benefit from PAH-specific therapies and have experienced worse clinical outcomes compared to other PAH subgroups. We and others have shown that in SSc-PAH, pathophysiologic differences at the molecular, cellular, and tissue levels underlie observed differences in clinical outcomes. A detailed understanding of the molecular aberration present in SSc-PAH versus idiopathic PAH (IPAH) might allow for exploitation of aberrant signaling pathways that are unique to SSc-PAH (and/or present in both of these two common PAH subtypes) for drug targeting. Recently, the approval of sotatercept, a novel ligand-trap molecule that targets TGF-beta signaling in PAH, was based on randomized controlled trial data demonstrating clinical improvement in patients already treated with drugs targeting NO, endothelin, and/or prostacyclin signaling. The success of sotatercept therefore lends credence to the notion that targeting as-yet unaddressed molecular aberrancies can bring about additional clinical benefit. Most previous omics investigations in PAH have examined circulating plasma or serum. With this study, we sought to identify distinct and overlapping gene expression patterns in SSc-PAH versus IPAH human lung tissue as a means of implicating abnormal biological processes, including inferred gene regulation and cell signaling, unique to the organ manifesting disease. To maximize biologic insight, we took a single-cell approach to RNA sequencing, in contrast to the bulk sequencing performed in most previous PAH studies. Finally, we leveraged cell-specific gene expression patterns and established computational methods to identify small molecule compounds with high potential to reverse disease-specific expression signatures, as a means of prioritizing candidates for drug repositioning. We posit that generation of phenotype-specific high-dimensional omics datasets, such as this one, will enable a precision-targeted approach to molecular aberration that might improve therapeutic responses and resolve heterogeneous treatment effects, thereby improving clinical outcomes across PAH subtypes.
-
03 GSE169471 将3例肺动脉高压患者肺组织与6例健康对照肺组织进行比较,采用单细胞RNA测序分析不同细胞类型转录组差异。肺组织经胶原酶A/DNA酶I消化后制备成单细胞悬液,通过70微米滤膜过滤并重悬于含0.04% BSA的PBS中。使用10X Genomics Chromium仪器完成单细胞RNA测序,比较内皮细胞、周细胞/平滑肌细胞、成纤维细胞和巨噬细胞簇的转录组特征,检测差异基因表达及基因通路变化。
设计将3例肺动脉高压患者肺组织与6例健康对照肺组织进行比较,采用单细胞RNA测序分析不同细胞类型转录组差异。肺组织经胶原酶A/DNA酶I消化后制备成单细胞悬液,通过70微米滤膜过滤并重悬于含0.04% BSA的PBS中。使用10X Genomics Chromium仪器完成单细胞RNA测序,比较内皮细胞、周细胞/平滑肌细胞、成纤维细胞和巨噬细胞簇的转录组特征,检测差异基因表达及基因通路变化。
摘要Despite recent improvements in management of idiopathic pulmonary arterial hypertension, mortality remains high. Understanding the alterations in the transcriptome–phenotype of the key lung cells involved could provide insight into the drivers of pathogenesis. In this study, we examined differential gene expression of cell types implicated in idiopathic pulmonary arterial hypertension from lung explants of patients with idiopathic pulmonary arterial hypertension compared to control lungs. After tissue digestion, we analyzed all cells from three idiopathic pulmonary arterial hypertension and six control lungs using droplet-based single cell RNA-sequencing. After dimensional reduction by t-stochastic neighbor embedding, we compared the transcriptomes of endothelial cells, pericyte/smooth muscle cells, fibroblasts, and macrophage clusters, examining differential gene expression and pathways implicated by analysis of Gene Ontology Enrichment. We found that endothelial cells and pericyte/smooth muscle cells had the most differentially expressed gene profile compared to other cell types. Top differentially upregulated genes in endothelial cells included novel genes: ROBO4, APCDD1, NDST1, MMRN2, NOTCH4, and DOCK6, as well as previously reported genes: ENG, ORAI2, TFDP1, KDR, AMOTL2, PDGFB, FGFR1, EDN1, and NOTCH1. Several transcription factors were also found to be upregulated in idiopathic pulmonary arterial hypertension endothelial cells including SOX18, STRA13, LYL1, and ELK, which have known roles in regulating endothelial cell phenotype. In particular, SOX18 was implicated through bioinformatics analyses in regulating the idiopathic pulmonary arterial hypertension endothelial cell transcriptome. Furthermore, idiopathic pulmonary arterial hypertension endothelial cells upregulated expression of FAM60A and HDAC7, potentially affecting epigenetic changes in idiopathic pulmonary arterial hypertension endothelial cells. Pericyte/smooth muscle cells expressed genes implicated in regulation of cellular apoptosis and extracellular matrix organization, and several ligands for genes showing increased expression in endothelial cells. In conclusion, our study represents the first detailed look at the transcriptomic landscape across idiopathic pulmonary arterial hypertension lung cells and provides robust insight into alterations that occur in vivo in idiopathic pulmonary arterial hypertension lungs.
-
04 GSE335228 将3例健康对照组(con1-con3)与3例肺动脉高压(PH)患者组(PH1-PH3)的肺组织样本进行单细胞RNA测序,比较两组间细胞转录特征差异。所有样本均通过机械破碎与酶解制备单细胞悬液,采用10× Genomics平台构建文库,测序于Illumina NovaSeq平台完成。检测覆盖总RNA的转录组特征,未涉及混池或特定处理条件。
设计将3例健康对照组(con1-con3)与3例肺动脉高压(PH)患者组(PH1-PH3)的肺组织样本进行单细胞RNA测序,比较两组间细胞转录特征差异。所有样本均通过机械破碎与酶解制备单细胞悬液,采用10× Genomics平台构建文库,测序于Illumina NovaSeq平台完成。检测覆盖总RNA的转录组特征,未涉及混池或特定处理条件。
摘要Background: Pulmonary hypertension (PH) is a life-threatening cardiovascular disorder characterized by irreversible pulmonary vascular remodeling and poor prognosis. RNA pseudouridylation, the most evolutionarily conserved RNA epigenetic modification, and its catalytic enzyme pseudouridine synthase 7 (PUS7) remained uncharacterized in PH, representing a major gap in understanding the epigenetic pathogenesis of the disease. Methods: We generated the first single-base resolution pseudouridine (Ψ) landscape in lung tissues of PH patients using bisulfite-induced deletion sequencing (BID-seq). PUS7 expression was analyzed in hypoxic pulmonary artery endothelial cells (PAECs), the lung tissues of PH patients, and Su5416-hypoxia rodent model. The functional roles of PUS7 were investigated through genetic manipulation (PUS7-deficiency cells, AAV-mediated overexpression, endothelial cell-specific knockdown, and heterozygous knockout mice) and pharmacological inhibition using NSC107512. Results: BID-seq revealed global Ψ dysregulation in the PH patient lung tissues. Among PUS family members, PUS7 was the most markedly upregulated in these tissues and in the hypoxic PAECs. Both gene knockdown and pharmacological inhibition with NSC107512 ameliorated PH, whereas AAV-mediated PUS7 overexpression exacerbated disease progression. RNA immunoprecipitation sequencing and mutagenesis studies demonstrated that PUS7 bound to and catalyzed Ψ at position 688 of Transforming Growth Factor Beta Induced Protein (TGFBI) mRNA, thereby stabilizing TGFBI and activating Phosphatidylinositol 3 Kinase (PI3K)-Protein Kinase B (AKT) signaling pathway. Furthermore, hypoxia-inducible factor 2α (HIF-2α) directly bound the PUS7 promoter, estabilishing a HIF-2α/PUS7/TGFBI/PI3K-AKT positive feedback loop that drives PH pathogenesis. Conclusions: PUS7-mediated pseudouridylation serves as a novel epigenetic driver of PH via the HIF-2α/PUS7/TGFBI/PI3K-AKT axis, positioning PUS7 as a promising therapeutic target for this devastating disease.
-
05 GSE228643 对人类肺动脉组织进行单细胞RNA测序,分析3例肺动脉高压伴肺纤维化(PHPF_1, PHPF_2, PHPF_3)样本与2例健康对照(Donor_4, Donor_5)的基因表达差异,比较两组间肺动脉内皮细胞亚群组成及转录特征变化。
设计对人类肺动脉组织进行单细胞RNA测序,分析3例肺动脉高压伴肺纤维化(PHPF_1, PHPF_2, PHPF_3)样本与2例健康对照(Donor_4, Donor_5)的基因表达差异,比较两组间肺动脉内皮细胞亚群组成及转录特征变化。
摘要Dysfunction of pulmonary arterial endothelial cells (PAECs) is associated with the development and progression of vascular pathology. However, it remains unknown how pulmonary hypertension (PH) affects cellular composition and transcriptomic profile of pulmonary endothelium. Here, we have undertaken a single-cell, compartment specific approach to characterise alterations in PAECs associated with two different types of PH, i.e., pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with pulmonary fibrosis (PHPF). Our unbiased analysis showed that endothelium of medium / small caliber pulmonary arteries is composed of three subsets of endothelial cells (ECs). The analysis of healthy and PH endothelium revealed that the three populations are persistently represented in remodelled arteries. Additionally, an exploratory analysis of human aorta (AO) and coronary arteries (CA) endothelium revealed that, although similar gene expression patterns were noticeable, PAECs subpopulations proportions differs significantly from pulmonary arteries (PA) endothelium. To address whether EC heterogeneity is a prime feature of human endothelium, we also performed a similar analysis in a murine model of hypoxia, revealing that similar EC populations were evident in this animal model. Comparative analysis of EC subpopulations in healthy and PH EC identified a common genetic deregulation accompanying vascular remodelling. Even though murine EC displayed some similarities with human EC subpopulations, the intense re-programming associated with hypoxia associated vascular remodelling displayed significant differences compared to the human disease. Finally, in depth comparative analysis of PAH and PHPF EC highlighted the development of disease-specific transcriptomic alterations in the three populations. Therefore, characterisation of transcriptomic differences in the endothelial bed of PAH and PHPF patients can facilitate identification of novel, disease-specific therapeutic targets.
人源空转
Human · Spatial
-
01 GSE256539 对11例肺动脉高压(IPAH)肺组织和5例对照肺动脉组织进行数字空间转录组学分析,分别采集plexiform、obliterative、intima+media hypertrophy、adventitia等病变区域,比较其转录组特征与对照组的差异。ROI选择基于组织学识别,通过连续切片分析并结合CD31、SMA和CD45标记定义病变类型。所有样本经GeoMx Nanostring平台处理后进行全基因组测序。
设计对11例肺动脉高压(IPAH)肺组织和5例对照肺动脉组织进行数字空间转录组学分析,分别采集plexiform、obliterative、intima+media hypertrophy、adventitia等病变区域,比较其转录组特征与对照组的差异。ROI选择基于组织学识别,通过连续切片分析并结合CD31、SMA和CD45标记定义病变类型。所有样本经GeoMx Nanostring平台处理后进行全基因组测序。
摘要Idiopathic Pulmonary Arterial Hypertension (IPAH) is a severe human disease, characterized by extensive pulmonary vascular remodeling due to plexiform and obliterative lesions, media hypertrophy, and alterations of adventitia. The objective of the study was to test the hypothesis that microscopic IPAH vascular lesions express unique molecular profiles, which collectively are different from control pulmonary arteries. We used digital spatial transcriptomics to profile the genome-wide differential transcriptomic signature of key pathological lesions (plexiform, obliterative, intima+media hypertrophy, and adventitia) in IPAH lungs (n= 11) and compared these data to the intima+media and adventitia of control pulmonary artery (n=5). The IPAH lesions and pulmonary artery compartments were defined by the analyses of hematoxylin-eosin stained serial section, aided by labeling with CD31 (for endothelial cells), smooth muscle cell actin (SMA), and CD45 for inflammatory mononuclear cells, also in serial sections. Approximately 12 regions of interest (ROI) were sampled from a histological section of a paraffin-embedded block of each lung, which was selected based on the finding of enrichment for IPAH lesions or control pulmonary arteries.
人源bulk 转录组
Human · Bulk RNA-seq
-
01 GSE254617 对肺动脉高压患者和肺移植供体肺组织进行RNA测序,比较其基因表达差异。研究整合了临床病理数据、全基因组关联研究、贝叶斯调控网络、单细胞转录组学和药理转录组学数据,共包含148个GSM样本。
设计对肺动脉高压患者和肺移植供体肺组织进行RNA测序,比较其基因表达差异。研究整合了临床病理数据、全基因组关联研究、贝叶斯调控网络、单细胞转录组学和药理转录组学数据,共包含148个GSM样本。
摘要Integrative multiomics can elucidate pulmonary arterial hypertension (PAH) pathobiology but procuring human PAH lung samples is rare. Here, we leverage transcriptomic profiling and deep phenotyping of the largest multicenter PAH lung biobank to date (96 disease and 52 control) by integration with clinicopathologic data, genome-wide association studies, Bayesian regulatory networks, single-cell transcriptomics, and pharmacotranscriptomics. We identify two potentially protective gene network modules associated with vascular cells, and we validated ASPN, coding for asporin, as a key hub gene that is upregulated as a compensatory response to counteract PAH. Specifically, we find that asporin is upregulated in lungs and plasma of multiple independent PAH cohorts and correlates with reduced PAH severity. We show asporin inhibits proliferation and TGF-β/pSMAD2/3 signaling in pulmonary artery smooth muscle cells from PAH lungs. Finally, we demonstrate in Sugen-hypoxia rats that ASPN knockdown exacerbated PAH while recombinant asporin attenuated PAH. Our integrative systems biology approach to dissect the PAH lung transcriptome uncovered asporin as a novel protective target with therapeutic potential in PAH.
-
02 GSE24988 研究对象为接受肺移植的肺纤维化(PF)患者肺组织,按肺动脉压力分为严重PH(mPAP>40 mmHg,n=17)、无PH(mPAP<20 mmHg,n=22)及中间PH组(mPAP 21-39 mmHg,n=45)和验证集(n=32)。采用Affymetrix微阵列分析基因表达谱,比较严重PH组与无PH组的差异,并在中间PH组和验证集中验证聚类分析结果。
设计研究对象为接受肺移植的肺纤维化(PF)患者肺组织,按肺动脉压力分为严重PH(mPAP>40 mmHg,n=17)、无PH(mPAP<20 mmHg,n=22)及中间PH组(mPAP 21-39 mmHg,n=45)和验证集(n=32)。采用Affymetrix微阵列分析基因表达谱,比较严重PH组与无PH组的差异,并在中间PH组和验证集中验证聚类分析结果。
摘要Pulmonary Hypertension (PH) is a frequent complication of Pulmonary Fibrosis (PF). PH can be seen in PF in the abscence of hypoxemia, irrespective of the degree of fibrosis. At the same time, a consistent number of patients with advanced PF never develop PH. The pathogenesis of PH secondary to PF remains unclear. PF patients are often referred to lung transplantation, but they present a higher incidence of pimary graft dysfunction than other diseases. The cause of this is unknown, and the relationship with PH remains unclear. We used microarray to identifiy the gene expression profiles in PF patients with and without PH
-
03 GSE117261 对58例肺动脉高压(PAH)患者和25例对照的肺组织进行基因表达微阵列分析,比较不同PAH亚型(IPAH、WHO 4、Failed Donor等)、临床分组(all PAH、FD)及性别差异的基因表达模式。检测采用RNA微阵列技术,样本为人类肺组织,对照组来自未匹配供体,PAH组包含移植肺组织样本,所有样本经RNALater保存后低温存储。
设计对58例肺动脉高压(PAH)患者和25例对照的肺组织进行基因表达微阵列分析,比较不同PAH亚型(IPAH、WHO 4、Failed Donor等)、临床分组(all PAH、FD)及性别差异的基因表达模式。检测采用RNA微阵列技术,样本为人类肺组织,对照组来自未匹配供体,PAH组包含移植肺组织样本,所有样本经RNALater保存后低温存储。
摘要Rationale: Pulmonary arterial hypertension (PAH) is characterized by increased pulmonary artery pressure and vascular resistance, typically leading to right heart failure and death. Current therapies improve quality of life of the patients but have a modest effect on long-term survival. A detailed transcriptomics and systems biology view of the PAH lung is expected to provide new testable hypotheses for exploring novel treatments. Objectives: Complete transcriptomics analysis of PAH and control lung tissue to develop disease-specific and clinical data/tissue pathology gene expression classifiers from expression datasets. Gene expression data were integrated into pathway analyses. Methods: Gene expression microarray data was collected from 58 PAH and 25 control lung tissues. The strength of the dataset and its derived disease classifier was validated using multiple approaches. Pathways and upstream regulators analyses was completed with standard and novel graphical approaches. Measurements and Main Results: The PAH lung dataset identified expression patterns specific to PAH subtypes, clinical parameters, and lung pathology variables. Pathway analyses indicate the important global role tumor necrosis factor and transforming growth factor signaling pathways. In addition, novel upstream regulators and insight into the cellular and innate immune responses driving PAH were identified. Finally, WNT-signaling pathways may be a major determinant underlying the observed sex differences in PAH. Conclusion: This study provides a transcriptional framework for the PAH-diseased lung, supported by previously reported findings, and will be a valuable resource to PAH research community. Our investigation revealed novel potential targets and pathways amenable to further study in a variety of experimental systems.
-
04 GSE236251 对左心疾病伴或不伴肺动脉高压患者的肺动脉干样本与健康心脏供体进行bulk RNA测序,比较不同组别间基因表达差异。样本在心脏移植手术中获取并液氮速冻,采用TRIzol-RNA提取法,通过RNA-Seq技术分析外基质成分转录调控变化,识别肺动脉高压相关病理机制。
设计对左心疾病伴或不伴肺动脉高压患者的肺动脉干样本与健康心脏供体进行bulk RNA测序,比较不同组别间基因表达差异。样本在心脏移植手术中获取并液氮速冻,采用TRIzol-RNA提取法,通过RNA-Seq技术分析外基质成分转录调控变化,识别肺动脉高压相关病理机制。
摘要Pulmonary hypertension worsens outcome in left heart disease. Stiffening of the pulmonary artery may drive this pathology by increasing right ventricular dysfunction and lung vascular remodeling. We showed that pulmonary arteries from patients with left heart disease are characterized by increased stiffness that correlates with impaired pulmonary hemodynamics. Pulmonary arteries in left heart disease patients with pulmonary hypertension were characterized by degradation of elastic fibers paralleled by an accumulation of fibrillar collagens. We utilized RNA sequencing to identify differentially expressed genes regulating extracellular matrix remodeling in pulmonary arteries of left heart disease patients with or without pulmonary hypertension, in comparison to healthy-heart donor controls. As such we identified that transcriptional deregulation of extracellular matrix constituents and their regulators precedes clinical pulmonary hypertension, and therefore might be a pathomechanism that drives pulmonary arterial remodeling and stiffening in left heart disease.
-
05 GSE113439 对肺动脉高压(PAH)患者及正常对照的肺组织进行基因表达谱分析,其中PAH组包含6例特发性PAH、4例结缔组织病相关PAH、4例先天性心脏病相关PAH和1例慢性血栓栓塞性肺动脉高压(CTEPH)患者,正常对照为肺癌切除术中获取的肺组织边缘样本。采用Affymetrix微阵列平台检测总RNA表达,通过量化归一化和中位数多项式技术生成表达值,比较不同疾病状态下的基因表达差异。
设计对肺动脉高压(PAH)患者及正常对照的肺组织进行基因表达谱分析,其中PAH组包含6例特发性PAH、4例结缔组织病相关PAH、4例先天性心脏病相关PAH和1例慢性血栓栓塞性肺动脉高压(CTEPH)患者,正常对照为肺癌切除术中获取的肺组织边缘样本。采用Affymetrix微阵列平台检测总RNA表达,通过量化归一化和中位数多项式技术生成表达值,比较不同疾病状态下的基因表达差异。
摘要Pulmonary arterial hypertension (PAH) is the best characterized and most studied type of pulmonary hypertension, classified as Group I according to the international guidelines, and hemodinamically defined as pre-capillary pulmonary hypertension. Our analysis was focused on the role of the osteopontin gene in the transcriptional profile of PAH. We used microarray to identifiy the gene expression profiles in patients with PAH and in normal controls.
-
06 GSE53408 对人类肺组织进行基于阵列的表达分析,比较11例正常对照与12例严重肺动脉高压患者的代谢组学特征。
设计对人类肺组织进行基于阵列的表达分析,比较11例正常对照与12例严重肺动脉高压患者的代谢组学特征。
摘要Although multiple gene and protein expression have been extensively profiled in human pulmonary arterial hypertension (PAH), the mechanism for the development and progression of pulmonary hypertension remains elusive. Analysis of the global metabolomic heterogeneity within the pulmonary vascular system leads to a better understanding of disease progression. Using a combination of high-throughput liquid-and-gas-chromatography-based mass spectrometry, we showed unbiased metabolomic profiles of disrupted glycolysis, increased TCA cycle, and fatty acid metabolites with altered oxidation pathways in the severe human PAH lung. The results suggest that PAH has specific metabolic pathways contributing to increased ATP synthesis for the vascular remodeling process in severe pulmonary hypertension. These identified metabolites may serve as potential biomarkers for the diagnosis of severe PAH. By profiling metabolomic alterations of the PAH lung, we reveal new pathogenic mechanisms of PAH in its later stage, which may differ from the earlier stage of PAH, opening an avenue of exploration for therapeutics that target metabolic pathway alterations in the progression of PAH.
-
07 GSE272776 对肺动脉高压患者和对照组的肺组织进行RNA-seq、4D Label-free蛋白质组学及磷酸化蛋白质组学检测,比较两组间mRNA、蛋白质和磷酸化蛋白的差异。样本编号为LUN 1-8(PAH患者)和NC 1-8(对照),共16个独立样本,按总单位数与组数估计每组8个。采用Trizol试剂提取总RNA,使用NEBNext® Ultra™ RNA Library Prep Kit构建测序库,检测对象为人类肺组织。
设计对肺动脉高压患者和对照组的肺组织进行RNA-seq、4D Label-free蛋白质组学及磷酸化蛋白质组学检测,比较两组间mRNA、蛋白质和磷酸化蛋白的差异。样本编号为LUN 1-8(PAH患者)和NC 1-8(对照),共16个独立样本,按总单位数与组数估计每组8个。采用Trizol试剂提取总RNA,使用NEBNext® Ultra™ RNA Library Prep Kit构建测序库,检测对象为人类肺组织。
摘要Pulmonary arterial hypertension (PAH), a fatal disease, is characterized by pulmonary vascular remodeling and vascular resistance. However, the molecular mechanisms underlying the pathogenesis of PAH remained to be incompletely understood. RNA-seq, 4D Label-free proteomics and phosphoproteomics were used to detect the levels of mRNA, proteins, and phosphoproteins in lung tissues from PAH patients, respectively. Parallel reaction monitoring (PRM) was carried out to verify the expression of the differentially expressed proteins. In total, 967 differentially expressed genes (|log2FoldChange|>1 and p<0.05), 764 differentially expressed proteins and 411 phosphoproteins were observed after data filtering (|log2FoldChange|>1 and p<0.05) in lung tissues of PAH patients as compared with the control group. Integrated analysis of the three omic measures revealed that the biological processes involving inflammation, ion channel and metabolism were closely associated with PAH. Several signaling pathways, such as ferroptosis, HIF-1, PI3K-AKT, and Rap1 might be related to the development of PAH. This study combined multi-omics characteristic profiling to find out the changed genes or proteins that contributed to a detailed pathogenic of PAH. It would have the benefit of looking for the novel and effective treatment targets and therapeutic drugs for PAH patients.
人源·鼠源单细胞
Human · Mouse · Single-cell
-
01 GSE210248 对人类肺动脉(来自肺动脉高压影响肺与健康供体)及小鼠肺动脉(来自12周龄雄性小鼠,暴露于常氧或低氧环境)进行单细胞RNA测序,比较不同疾病状态与氧合条件下的细胞组成差异及基因表达特征。
设计对人类肺动脉(来自肺动脉高压影响肺与健康供体)及小鼠肺动脉(来自12周龄雄性小鼠,暴露于常氧或低氧环境)进行单细胞RNA测序,比较不同疾病状态与氧合条件下的细胞组成差异及基因表达特征。
摘要A central feature of progressive vascular remodeling is altered smooth muscle cell (SMC) homeostasis; however, the understanding of how different cell populations contribute to this process is limited. Here, we utilized single cell RNA sequencing to provide insight into cellular composition changes within isolated pulmonary arteries (PA) from pulmonary arterial hypertension (PAH) and donor lungs. Our results revealed that remodeling skewed the balanced communication network between immune and structural cells, in particular SMC. Comparative analysis with murine PA showed that human PA harbor heterogeneous SMC populations with an abundant intermediary cluster displaying a gradient transition between SMC and adventitial fibroblasts. Transcriptionally distinct SMC populations were enriched in specific biological processes and could be distinguished into four major clusters: oxygen sensing (enriched in pericytes), contractile, synthetic and fibroblast-like. End-stage remodeling was associated with phenotypic shift of pre-existing SMC populations and accumulation of synthetic SMC in neointima. Distinctly regulated genes in clusters built non-redundant regulatory hubs encompassing stress response and differentiation regulators. The current study provides a blueprint of cellular and molecular changes on a single cell level that are defining pathological vascular remodeling process.
鼠源单细胞
Mouse · Single-cell
-
01 GSE215933 对肺动脉高压相关转基因小鼠肺内皮细胞进行单细胞RNA测序,比较EC-Atm-/-、EC-Bmpr2-/-及对照组在再氧合处理后的基因表达差异。研究对象为肺内皮细胞,样本按基因型分为EC-Atm-/-(5个样本)、EC-Bmpr2-/-(5个样本)和对照组(4个样本),均经历再氧合处理。检测方式为单细胞RNA测序,主要比较不同基因型肺内皮细胞在再氧合条件下的转录组变化。
设计对肺动脉高压相关转基因小鼠肺内皮细胞进行单细胞RNA测序,比较EC-Atm-/-、EC-Bmpr2-/-及对照组在再氧合处理后的基因表达差异。研究对象为肺内皮细胞,样本按基因型分为EC-Atm-/-(5个样本)、EC-Bmpr2-/-(5个样本)和对照组(4个样本),均经历再氧合处理。检测方式为单细胞RNA测序,主要比较不同基因型肺内皮细胞在再氧合条件下的转录组变化。
摘要Pulmonary arterial hypertension (PAH) is a progressive disease in which pulmonary arterial (PA) endothelial cell (EC) dysfunction is associated with unrepaired DNA damage. BMPR2 is the most common mutant gene in PAH. We report that human PAEC with reduced BMPR2 have persistent DNA damage in room air after hypoxic exposure (reoxygenation), as do mice with EC deletion of Bmpr2 (EC-Bmpr2-/-) and persistent pulmonary hypertension. Similar findings are observed in PAEC with loss of the DNA damage sensor ATM, and in mice with Atm deleted in EC (EC-Atm-/-). Gene expression analysis of EC-Atm-/- and EC-Bmpr2-/- lung EC revealed reduced Foxf1, a transcription factor with relative selectivity for lung EC. Reducing FOXF1 in control PAEC induced DNA damage and impaired angiogenesis whereas transfection of FOXF1 in PAH PAEC repaired DNA damage and restored angiogenesis. Lung EC targeted delivery of Foxf1 to reoxygenated EC-Bmpr2-/- mice repaired DNA damage, induced angiogenesis and reversed pulmonary hypertension.
-
02 GSE294702 对肺动脉高压相关疾病模型小鼠进行单细胞RNA测序,比较gcn2-/-与野生型小鼠CD45+和CD45-细胞类型的转录组差异,分析其肺静脉闭塞性疾病表型变化。
设计对肺动脉高压相关疾病模型小鼠进行单细胞RNA测序,比较gcn2-/-与野生型小鼠CD45+和CD45-细胞类型的转录组差异,分析其肺静脉闭塞性疾病表型变化。
摘要Biallelic mutations in eukaryotic translation initiation factor 2 α kinase 4, EIF2AK4 (which encodes general control nonderepressible 2, GCN2) underpin heritable forms of pulmonary veno-occlusive disease (PVOD), a rare and fatal form of pulmonary hypertension. The mechanisms linking these remain uncharacterised. We demonstrate for the first time that homozygous loss of gcn2 is sufficient to cause mild pulmonary hypertension in mice. Single-cell transcriptomics of mouse lungs identified adventitial fibroblasts as having the greatest GCN2-dependent transcriptional differences, implicating them as key players in this model of PVOD. The most significantly upregulated pathways in gcn2-/- adventitial fibroblasts were inflammatory, and therefore we went on to demonstrate a pro-inflammatory phenotype in gcn2-/- mouse embryonic fibroblasts and gcn2-/- mice. When chronically exposed to lipopolysaccharide, the pulmonary hypertensive phenotype of gcn2-/- mice is exaggerated. Genetic ablation of interleukin-6 completely rescues both baseline and LPS-exaggerated pulmonary hypertensive phenotype. In an orthogonal murine model of pulmonary hypertension induced by exposure to mitomycin-C, deletion of interleukin-6 again rescued the pulmonary vascular phenotype. Targeting Il6-dependent pathways may be useful in treating this deadly disease.
-
03 GSE314055 对小鼠肺组织内皮细胞进行单细胞RNA测序,比较Fosl2tg与野生型、RAGko与FRA_RAGko等基因型及不同处理条件下的基因表达差异。
设计对小鼠肺组织内皮细胞进行单细胞RNA测序,比较Fosl2tg与野生型、RAGko与FRA_RAGko等基因型及不同处理条件下的基因表达差异。
摘要Systemic Sclerosis (SSc) is characterized by fibrosis and vasculopathy affecting the skin and internal organs, leading to multi-organ dysfunction. Injury of microvascular ECs in SSc impairs blood flow and causes tissue ischemia, leading to vascular complications such as Raynaud’s, digital ulcers, and pulmonary hypertension (PH). PH in SSc presents as group 1 pulmonary arterial hypertension (PAH) or as group 3 PH related to hypoxia and interstitial lung disease (ILD), both major causes of mortality. Analysis of multiome data from SSc ILD-PH lungs inferred transcription factors regulating EC phenotype, including FOSL2. Overexpression of FOSL2 in transgenic mice (Fosl2tg) leads to vascular changes mirroring human SSc-PH, such as intimal thickening and fibrosis. ScRNA-seq analysis of altered EC gene expression in the Fosl2tg mice showed strong overlap with altered EC gene in SSc-ILD-PH. Overlapping as well as discrete EC gene expression in SuGene/hxpoxia- and hypoxia-treated mice suggested that FOSL2 regulates both hypoxia-dependent and independent pathways in Fosl2tg mice and SSc-ILD-PH. The deep learning model, ChromBPNet, inferred increased AP-1 binding at base pair resolution in SSc-ILDPH ECs and binding to the same motifs was found upon FOSL2 overexpression in primary vascular ECs, highlighting FOSL2’s key role in driving the pathological changes seen in SSc-ILDPH.
-
04 GSE316584 将小鼠分为三组:缺氧环境(Su/Hx)下每周注射 Sugen 并于第 3 周接受 LNA-Ctrl 或 LNA-224 气管内注射处理,以及常氧环境(Nox)下第 3 周接受 LNA-Ctrl 注射处理,所有小鼠于第 6 周处死并采集肺组织进行 scRNA-seq 分析,比较不同处理条件下肺组织单核转录组差异。
设计将小鼠分为三组:缺氧环境(Su/Hx)下每周注射 Sugen 并于第 3 周接受 LNA-Ctrl 或 LNA-224 气管内注射处理,以及常氧环境(Nox)下第 3 周接受 LNA-Ctrl 注射处理,所有小鼠于第 6 周处死并采集肺组织进行 scRNA-seq 分析,比较不同处理条件下肺组织单核转录组差异。
摘要Mice were maintained under hypoxic conditions for 3 weeks with weekly Sugen injections and were then randomized to receive an intratracheal injection of a chemically modified antisense oligonucleotide targeting miR-224 (LNA-224) or a control antimiR (LNA-Ctrl; 5 mg/kg each) at week 3. A separate group of mice was maintained under normoxic conditions and received an intratracheal injection of LNA-Ctrl at week 3 (Nox). All mice were sacrificed at week 6, and scRNA-seq analyses were performed.
-
05 GSE229875 对肺动脉高压模型小鼠和对照小鼠的肺组织中 Th2 细胞进行单细胞 RNA 测序,比较不同基因型(Wild-type 和 USP7 KO)及处理条件(IL-2、IL-4 培养)下的转录组差异,同时分析脾脏组织中 Th2 细胞的分化过程。
设计对肺动脉高压模型小鼠和对照小鼠的肺组织中 Th2 细胞进行单细胞 RNA 测序,比较不同基因型(Wild-type 和 USP7 KO)及处理条件(IL-2、IL-4 培养)下的转录组差异,同时分析脾脏组织中 Th2 细胞的分化过程。
摘要Uncontrolled type 2 immunity by type 2 helper T (Th2) cells causes intractable allergic diseases; however, whether the interaction of CD4+ T cells shapes the pathophysiology of allergic diseases remains unclear. We identified a subset of Th2 cells that produced the serine proteases granzyme A and B early in differentiation. Granzymes cleave protease-activated receptor (Par)-1 and induce phosphorylation of p38 mitogen-activated protein kinase (MAPK), resulting in the enhanced production of IL-5 and IL-13 in both mouse and human Th2 cells. Ubiquitin-specific protease 7 (USP7) regulates IL-4-induced phosphorylation of STAT3, resulting in granzyme production during Th2 cell differentiation. Genetic deletion of Usp7 or Gzma and pharmacological blockade of granzyme B ameliorated allergic airway inflammation. Furthermore, PAR-1+ and granzyme+ Th2 cells were colocalized in nasal polyps from patients with eosinophilic chronic rhinosinusitis. Thus, the USP7-STAT3-granzymes-Par-1 pathway is a potential therapeutic target for intractable allergic diseases.
-
06 GSE244864 对8周龄雄性C57BL/6J和STING-/-小鼠左肺组织进行单细胞RNA测序,比较两种基因型在常氧与慢性缺氧(4周10%氧气)处理下的基因表达差异。
设计对8周龄雄性C57BL/6J和STING-/-小鼠左肺组织进行单细胞RNA测序,比较两种基因型在常氧与慢性缺氧(4周10%氧气)处理下的基因表达差异。
摘要Gene expression profile at single cell level of whole lung cells from C57BL/6J mice or global STING knock-out mice (STING-/-), exposed to either room air or chronic hypoxia (4-week 10% oxygen). Study described in manuscript "A non-inteferon role of STING in pulmonary hypertension". We used scRNAseq to analyze the difference in pulmonary cells and different gene expression across populations between wild type and STING-/- underwent pulmonary hypertension induction with chronic hypoxia.
-
07 GSE154959 对小鼠肺内皮细胞进行单细胞 RNA 测序,比较健康对照与肺动脉高压(PAH)模型的转录组差异。健康对照组采用 Cdh5-CreERT2-TdTomato 小鼠,通过流式细胞术分离 TdTomato 阳性细胞,获取 ContA/ContB 两个样本;PAH 组使用 SU5416 联合慢性低氧暴露模型,三周内每周注射 20 mg/kg SU5416 并维持 10% 氧气环境,获取 PAH1/PAH2/PAH3 三个样本及 Cont1 对照样本。所有样本均来自肺组织,检测方式为 RNA-Seq,主要比较 PAH 组与健康对照组的内皮细胞转录特征差异。
设计对小鼠肺内皮细胞进行单细胞 RNA 测序,比较健康对照与肺动脉高压(PAH)模型的转录组差异。健康对照组采用 Cdh5-CreERT2-TdTomato 小鼠,通过流式细胞术分离 TdTomato 阳性细胞,获取 ContA/ContB 两个样本;PAH 组使用 SU5416 联合慢性低氧暴露模型,三周内每周注射 20 mg/kg SU5416 并维持 10% 氧气环境,获取 PAH1/PAH2/PAH3 三个样本及 Cont1 对照样本。所有样本均来自肺组织,检测方式为 RNA-Seq,主要比较 PAH 组与健康对照组的内皮细胞转录特征差异。
摘要(1) Rationale: Endothelial cell dysfunction plays a critical role in the development and pathogenesis of pulmonary arterial hypertension (PAH). (2) Objectives: We aimed to characterise the endothelial cell dynamics in PAH at a single cell resolution. (3) Methods: We carried out single-cell RNA sequencing of lung endothelial cells isolated from an endothelial cell lineage tracing mouse model in control and SU5416/Hypoxia-induced PAH conditions. (4) Measurements and Main Results: Endothelial cell populations corresponding to the different lung vessel types could be identified in both control and PAH mice. Differential gene expression analysis revealed novel global and vessel-type specific responses in endothelial cells due to PAH. Global changes included the up-regulation of the major histocompatibility complex class II pathway, supporting a role for endothelial cells in the inflammatory response in PAH. We also identified a PAH response specific to the second capillary EC population, with the up-regulation of genes involved in cell localization and angiogenesis. Comparison with human genetics and transcriptomics data revealed the regulation of four genes with variants associated to PAH and five genes up-regulated in endothelial cells in both human and mouse scRNA-seq. Among them, Aqp1 and Adam15 genes represent promising new candidates to target endothelial dysfunction. Finally, we identified zonation-dependent changes across the arteriovenous axis in PAH using an in-silico cell ordering approach and showed the up-regulation of the Serine/threonine-protein kinase Sgk1 at the junction between the macro- and micro-vasculature. (5) Conclusions: This study uncovers the murine endothelial cell transcriptomics changes in PAH at a high resolution, revealing novel candidates relevant to PAH.
-
08 GSE279244 研究对象为肺内皮细胞和间质细胞,取自野生型(WT)及肿瘤坏死因子α转基因(TNF-Tg)小鼠的肺组织,年龄分别为8、14和20周。采用单细胞RNA测序技术,使用Chromium Single-Cell 3′ Library & Gel Bead Kit(版本1.1;10x Genomics)制备文库,并通过Illumina NovaSeq6000平台测序。每组条件捕获5000-6000个细胞,测序深度为每个细胞50,000 reads。主要比较WT与TNF-Tg小鼠在不同年龄下的转录特征差异。
设计研究对象为肺内皮细胞和间质细胞,取自野生型(WT)及肿瘤坏死因子α转基因(TNF-Tg)小鼠的肺组织,年龄分别为8、14和20周。采用单细胞RNA测序技术,使用Chromium Single-Cell 3′ Library & Gel Bead Kit(版本1.1;10x Genomics)制备文库,并通过Illumina NovaSeq6000平台测序。每组条件捕获5000-6000个细胞,测序深度为每个细胞50,000 reads。主要比较WT与TNF-Tg小鼠在不同年龄下的转录特征差异。
摘要The pathobiology of pulmonary hypertension (PH) is complex and multiple cell types (endothelial, smooth muscle, fibroblast, pericyte) contribute to disease pathogenesis. However, the specific molecular crosstalk between endothelial and mesenchymal cells to promote PH is poorly characterized. We previously demonstrated that tumor necrosis factor alpha transgenic (TNF-Tg) mice have a severe PH phenotype.
-
09 GSE254338 将Cx3cr1+/GFP reporter小鼠的肺部间质巨噬细胞按对照组和Schistosoma IV挑战组分组,分别在0天、1天、3天、7天时间点收集,每个时间点从一对年龄和性别匹配的小鼠中分选并合并,进行单细胞RNA测序,比较不同处理组和时间点的IM亚群表达特征。
设计将Cx3cr1+/GFP reporter小鼠的肺部间质巨噬细胞按对照组和Schistosoma IV挑战组分组,分别在0天、1天、3天、7天时间点收集,每个时间点从一对年龄和性别匹配的小鼠中分选并合并,进行单细胞RNA测序,比较不同处理组和时间点的IM亚群表达特征。
摘要Schistosomiasis, a prevalent cause of pulmonary hypertension (PH) globally, triggers type 2 inflammation, with interstitial macrophages (IMs) derived from monocytes playing a crucial role. These IMs produce thrombospondin-1 (TSP-1), activating TGF-β and driving PH pathology. Two distinct IM subpopulations were identified: resident FOLR2+ IMs expressing monocyte recruitment factors, and recruited CCR2+ IMs expressing TSP-1. Upon exposure to Schistosoma, the CCR2+ subpopulation expanded. Flow cytometry and single-cell RNA sequencing confirmed these findings, revealing crosstalk between IM subpopulations. The resident FOLR2+ IMs increased expression of monocyte recruitment ligands, while the recruited CCR2+ IMs expressed elevated TSP-1, activating TGF-β and contributing to PH. This study provides insights into the complex interplay of IM subpopulations in Schistosoma-induced PH, shedding light on potential therapeutic targets for this global health concern.
-
10 GSE244309 对C57/BL6小鼠肺组织进行单细胞RNA测序,比较高脂饮食与L-NAME处理组和低脂饮食对照组的转录组差异。
设计对C57/BL6小鼠肺组织进行单细胞RNA测序,比较高脂饮食与L-NAME处理组和低脂饮食对照组的转录组差异。
摘要Goals and objectives of this study were to determine on a single-cell level transcriptomic changes that occur in the lungs of a murine model of heart failure with preserved ejection fraction caused by administration of high fat diet and eNOS inhibitor L-NAME.
鼠源空转
Mouse · Spatial
-
01 GSE277936 将Egln1Tie2Cre (KO)小鼠与同窝Egln1f/f (WT)对照的肺组织切片分别进行固定、切片和Xenium载玻片安装,采用Xenium平台开展空间转录组学与荧光原位杂交分析,比较两组基因表达差异。
设计将Egln1Tie2Cre (KO)小鼠与同窝Egln1f/f (WT)对照的肺组织切片分别进行固定、切片和Xenium载玻片安装,采用Xenium平台开展空间转录组学与荧光原位杂交分析,比较两组基因表达差异。
摘要We developed a method that utilizes floating mounting of thin sections of fixed frozen mouse lung tissue onto Xenium slides for the fluorescent in situ hybridization (FISH) and imaging–based spatial transcriptomics analysis of gene expression using the Xenium platform provided by 10X Genomics. Spatial transcriptomics techniques provide a comprehensive view by merging gene expression data with spatial context within their native tissue architecture. However, the Xenium pipeline has been validated only for formalin-fixed paraffin-embedded (FFPE) and fresh frozen sections by 10X Genomics. Notably, many researchers prefer paraformaldehyde-fixed cryosections for immunohistochemistry and in situ hybridization. In our study, we assessed the compatibility of standard fixed frozen mouse lung sections with the Xenium protocol. Our findings reveal that these sections not only align well with the Xenium platform but also offer superb imaging and gene expression quantification, even with limited number of genes in the Xenium panel. This protocol can serve as a valuable resource for preparing various tissues where FFPE and fresh frozen samples present challenges.
鼠源bulk 转录组
Mouse · Bulk RNA-seq
-
01 GSE183908 研究对象为肺血管,材料为 C57BL/6J 小鼠的总 RNA。将小鼠分为常压、慢性低氧及慢性低氧后重新暴露于常压的 1、3、7、14 天组,每组 8-12 只动物。通过激光显微切割提取肺血管组织,采用双色微阵列分析技术检测基因表达差异,比较不同处理条件下肺血管的转录组变化。
设计研究对象为肺血管,材料为 C57BL/6J 小鼠的总 RNA。将小鼠分为常压、慢性低氧及慢性低氧后重新暴露于常压的 1、3、7、14 天组,每组 8-12 只动物。通过激光显微切割提取肺血管组织,采用双色微阵列分析技术检测基因表达差异,比较不同处理条件下肺血管的转录组变化。
摘要Pulmonary hypertension (PH) is a life-threatening disease, characterized by excessive pulmonary vascular remodeling, leading to elevated pulmonary arterial pressure and right heart hypertrophy. PH is caused, among other factors, by chronic hypoxia, leading to hyper-proliferation of pulmonary arterial smooth muscle cells (PASMC) and apoptosis-resistant pulmonary microvascular endothelial cells (PMVEC). Upon re-exposure to normoxia, chronic hypoxia-induced PH in mice is reversible. In this study, we aim to identify novel candidate genes involved in pulmonary vascular remodeling specifically in the pulmonary vasculature.
-
02 GSE1909 对 BALB/c 小鼠整个肺组织进行微阵列分析,比较缺氧暴露不同天数(1、3、7、14、21 天)及恢复期(22、24、28、35 天)与时间匹配对照组的基因表达差异。每个时间点处理组与对照组各取 5 只小鼠肺组织混池,共设置 9 个时间点,每个时间点均进行 4 次重复检测(含 dye swapping)。
设计对 BALB/c 小鼠整个肺组织进行微阵列分析,比较缺氧暴露不同天数(1、3、7、14、21 天)及恢复期(22、24、28、35 天)与时间匹配对照组的基因表达差异。每个时间点处理组与对照组各取 5 只小鼠肺组织混池,共设置 9 个时间点,每个时间点均进行 4 次重复检测(含 dye swapping)。
摘要These microarray studies were performed using whole lungs of BALB/C mice during development of hypoxia-induced pulmonary hypertension (days 1-21) and resolution of pulmonary hypertension after return to normoxia (days 22-35) . Mice were sampled during nine time-points and each time-point was replicated 4 times (with dye swapping). Keywords = hypoxia Keywords = pulmonary hypertension Keywords: other
-
03 GSE316502 将野生型(B6/129SJ2)、全球CAV1敲除(Cav1-/-)及内皮细胞特异性恢复CAV1表达(Cav1-RC)小鼠按性别(雌性、雄性)分组,分别置于常氧或慢性缺氧(6周10%氧)环境中,采集肺组织进行bulk RNA测序,比较不同基因型和性别在两种处理条件下的转录组差异。样本量按总单位数35与组数估计。
设计将野生型(B6/129SJ2)、全球CAV1敲除(Cav1-/-)及内皮细胞特异性恢复CAV1表达(Cav1-RC)小鼠按性别(雌性、雄性)分组,分别置于常氧或慢性缺氧(6周10%氧)环境中,采集肺组织进行bulk RNA测序,比较不同基因型和性别在两种处理条件下的转录组差异。样本量按总单位数35与组数估计。
摘要Pulmonary arterial hypertension (PAH) is distinguished by elevated blood pressure and vascular resistance in the arteries of the lungs. Patients with PAH demonstrate pulmonary vascular remodeling, wall thickening, and a high rate of morbidity due to right heart failure. Notably, while female patients are more likely to develop PAH, male patients suffer from higher morbidity rates after diagnosis. The molecular mechanism(s) underlying PAH development is poorly understood, though heritable PAH linked to mutations in bone morphogenic protein receptor 2 (BMPR2) and caveolin-1 (CAV1) may provide novel insights into the disease’s pathophysiology. To interrogate this dynamic, we utilized a global CAV1 knockout (CAV1-KO) mouse model (CAV1-/-) in conjunction with chronic hypoxia to induce symptoms of PAH as demonstrated by hemodynamic and ECHO cardiography recordings. Both female and male CAV1-/- mice in chronic hypoxia demonstrated elevated right ventricular systolic pressure (RVSP) of 48.49mmHg and 47.78mmHg respectively. Female knockout mice started to die earlier in hypoxic conditions (4 wks), though male mice showed greater total mortality by the end of the 8 wks of hypoxia. In addition to wildtype controls, we compared this knockout mouse to endothelial-specific CAV1 reconstituted (CAV1-RC) knockouts and found that restoration of CAV1 expression only in endothelial cells (ECs) is sufficient to ameliorate PAH symptoms, highlighting the importance of vascular CAV1 in maintaining pulmonary artery function. RNA-sequencing of the lungs revealed that CAV1-/- is associated with downregulation of biological process gene pathways involved in cilium assembly in normoxic conditions for both sexes. In hypoxic conditions, CAV1 knockout in females leads to downregulation of BMP signaling, while male hypoxic CAV1-/- led to a significant increase in muscle cell development genes. Reconstitution of CAV1 in ECs lead to upregulation of immune signaling pathways, muscle cell development, and various cell differentiation pathways in both sexes. Females showed a unique upregulation of cilia-related pathways, while males demonstrated increased BMP signaling. These data indicate that muscle cell development, angiogenesis, cilia assembly, immune response, and BMP signaling pathways undergo sex-specific transcriptional regulation during PH development that may underlie sex differences in PH patient outcome.
-
04 GSE207324 将年轻C57BL6/j雄性小鼠按缺氧或常氧条件分组,并接受ABT-263(50mg/kg/day)或载体处理,每组6只(按总单位数24与组数4估计),采集肺组织进行RNA-Seq分析,比较不同处理与环境条件组合下的基因表达差异。
设计将年轻C57BL6/j雄性小鼠按缺氧或常氧条件分组,并接受ABT-263(50mg/kg/day)或载体处理,每组6只(按总单位数24与组数4估计),采集肺组织进行RNA-Seq分析,比较不同处理与环境条件组合下的基因表达差异。
摘要To explore the role played by senescent cells in mice models of pulmonary hypertension we exposed young C57BL6/j mice to 2 days hypoxia or normoxia and treated with senolytic drug ABT-263 (50mg/kg/day) or its vehicule. We then performed lung gene expression profiling analysis using data obtained from RNA-seq of 4 groups of mice (Normoxia+Vehicule; Normoxia+ABT-263; Hypoxia+Vehicule; Hypoxia+ABT-263)
-
05 GSE207256 将年轻C57BL6/j小鼠按缺氧或常氧条件暴露8天,并接受ABT-263(50mg/kg/day)或其载体治疗,采集肺组织进行RNA-seq分析,比较四种处理组(常氧+载体、常氧+ABT-263、缺氧+载体、缺氧+ABT-263)的基因表达差异。
设计将年轻C57BL6/j小鼠按缺氧或常氧条件暴露8天,并接受ABT-263(50mg/kg/day)或其载体治疗,采集肺组织进行RNA-seq分析,比较四种处理组(常氧+载体、常氧+ABT-263、缺氧+载体、缺氧+ABT-263)的基因表达差异。
摘要To explore the role played by senescent cells in mice models of pulmonary hypertension we exposed young C57BL6/j mice to 8 days hypoxia or normoxia and treated with senolytic drug ABT-263 (50mg/kg/day) or its vehicule. We then performed lung gene expression profiling analysis using data obtained from RNA-seq of 4 groups of mice (Normoxia+Vehicule; Normoxia+ABT-263; Hypoxia+Vehicule; Hypoxia+ABT-263)
-
06 GSE131425 将Arg2野生型和敲除型小鼠肺组织进行RNA测序,比较缺氧与常氧环境下两种基因型的转录组差异。实验对象为8-10周龄C57/129小鼠,分别暴露于10% O2(缺氧)或21% O2(常氧)环境28天,术后采集肺组织进行RNA提取与测序。
设计将Arg2野生型和敲除型小鼠肺组织进行RNA测序,比较缺氧与常氧环境下两种基因型的转录组差异。实验对象为8-10周龄C57/129小鼠,分别暴露于10% O2(缺氧)或21% O2(常氧)环境28天,术后采集肺组织进行RNA提取与测序。
摘要Increased arginase 2 protein expression is associated with endothelial dysfunction and pulmonary hypertension, likely by impairing NO production secondary to substrate availability. Hypoxia induces arginase 2 protein expression contributing to pulmonary vascular cell proliferation. Non-specific arginase inhibitors have been shown to prevent experimental pulmonary hypertension in animal models. RNA was isolated from whole lung tissue from adult (12-14 weeks) arginase 2 wild type and KO mice exposed to 21% O2 or 10% O2 for 28 days. Animals were sacrificed and the lungs collected and stored at -80°C . Total RNA was isolated with Trizol and used for RNA-seq. RNA-seq results indicate notable differentially expressed gene transcripts were evident in the Arg2 WT and Arg2 KO lungs. There were 25 unique transcripts identified (>2-fold change, p < 0.001) between the normoxia and hypoxia-exposed Arg2 WT. Interestingly, there was significantly greater differences in the Arg2 KO mice exposed to hypoxia compared to normoxia, with 188 unique transcripts (>2-fold change, p < 0.001) identified by RNA seq.
-
07 GSE315475 对C57BL/6野生型小鼠与VIP敲除型小鼠肺组织进行RNA-Seq测序,比较常氧(21% O2)与慢性缺氧(10% O2)4周处理下两组基因型的转录组差异。
设计对C57BL/6野生型小鼠与VIP敲除型小鼠肺组织进行RNA-Seq测序,比较常氧(21% O2)与慢性缺氧(10% O2)4周处理下两组基因型的转录组差异。
摘要We earlier reported spontaneous moderate pulmonary arterial hypertension in Vasoactive Intestinal Peptide (VIP) gene knockout mice. In the current study, we show accelerated pulmonary artery pressure changes associated with vascular and cardiac remodeling changes in VIP KO mice subjected to hypoxia compared to control wild-type C57BL/6 mice in hypoxia chambers. There is differential whole-lung RNA sequencing expression between baseline normoxia wild-type and VIP KO mice groups. Under conditions of hypoxia vs. normoxia, we observe upregulation of spatial biology expression of CD45 in VIP KO mice with hypoxia, but not in wild-type mice with hypoxia. Moreover, wild-type hypoxia mice express alpha-actin and CD31, which is not seen in the VIP KO hypoxia cohort. Human lung tissue from pediatric patients with idiopathic pulmonary arterial hypertension (PAH) lacks immunohistochemical evidence of VIP, supporting the concepts that VIP plays a critical role in the immunopathogenesis of pulmonary hypertension and VIP or its analogues may potentially be used to treat PAH.
-
08 GSE110131 对野生型、β-arrestin 1 -/- 和 β-arrestin 2 -/- 小鼠肺组织进行高通量 RNA 测序,比较其在常氧与慢性缺氧暴露下的转录组差异。每组小鼠在两种处理条件下均设三重重复,样本年龄为 8-12 周,采集肺组织后提取总 RNA 并通过 cDNA 文库策略进行单端 50bp 测序。
设计对野生型、β-arrestin 1 -/- 和 β-arrestin 2 -/- 小鼠肺组织进行高通量 RNA 测序,比较其在常氧与慢性缺氧暴露下的转录组差异。每组小鼠在两种处理条件下均设三重重复,样本年龄为 8-12 周,采集肺组织后提取总 RNA 并通过 cDNA 文库策略进行单端 50bp 测序。
摘要We found that β-arrestin 1 -/- mice were more sensitive to hypoxia-induced pulmonary arterial hypertension with increased right ventricle hypertrophy and higher right ventricle systolic pressure, while β-arrestin 2 -/- mice developed right ventricle hypertrophy comparable to wild type mice. Moreover, β-arrestin 1 -/- mice had worse right ventricle function than wild type mice in response to chronic hypoxia, whereas β-arrestin 2 -/- mice relatively preserved right ventricle function compared to wild type mice. To investigate the molecular mechanisms responsible for the worse PAH in β-arrestin 1 -/- mice, we performed lung transcriptome analysis of wild type, β-arrestin 1 -/-, and β-arrestin 2 -/- mice using high-throughput RNA-seq.
-
09 GSE87602 对缺氧小鼠肺部alveolar和interstitial巨噬细胞进行RNA测序,比较海平面与缺氧处理下不同时间点(4天、14天)的基因表达差异。将C57BL/6小鼠肺组织按alveolus和interstitial室分选,分别在海平面及模拟海拔18,000英尺条件下培养4天和14天,采集样本进行RNA-Seq分析,检测总RNA表达特征并对比不同处理时间与室别的差异。
设计对缺氧小鼠肺部alveolar和interstitial巨噬细胞进行RNA测序,比较海平面与缺氧处理下不同时间点(4天、14天)的基因表达差异。将C57BL/6小鼠肺组织按alveolus和interstitial室分选,分别在海平面及模拟海拔18,000英尺条件下培养4天和14天,采集样本进行RNA-Seq分析,检测总RNA表达特征并对比不同处理时间与室别的差异。
摘要Studies in various animal models suggest an important role for pulmonary macrophages in the pathogenesis of pulmonary hypertension (PH). Yet, the molecular mechanisms characterizing the functional macrophage phenotype relative to time and pulmonary localization/compartmentalization remain largely unknown. Here, we utilized a hypoxic murine model of PH in combination with flow cytometry assisted cell sorting (FACS) to quantify and isolate lung macrophages from two compartments over time and characterized their programing via RNA sequencing (RNAseq) approaches. In response to hypoxia, we found an early increase in macrophage number that was restricted to the interstitial/perivascular compartment, without recruitment of macrophages to the alveolar compartment or changes in the number of resident alveolar macrophages. Principle component analysis demonstrated significant differences in overall gene expression between alveolar (AMs) and interstitial macrophages (IMs) at baseline and after 4 and 14 days hypoxic exposure. AM’s at both day 4 and 14 and IM’s at day 4 shared a conserved “hypoxia program” characterized by mitochondrial dysfunction, pro-inflammatory gene activation and mTORC1 signaling, while IM’s at day 14 demonstrated a unique anti-inflammatory/ pro-reparative programming state. We conclude that the pathogenesis of vascular remodeling in hypoxic PH involves an early compartment independent activation of lung macrophages towards a conserved hypoxia program, with the development of compartment specific programs later on in the course of disease. Thus, harnessing time and compartment specific differences in lung macrophage polarization needs to be considered in the therapeutic targeting of macrophages in hypoxic PH and potentially other inflammatory lung diseases.
-
10 GSE49114 将8只实验组(Schistosoma诱导肺动脉高压)和8只对照组(无暴露)小鼠的全肺组织进行RNA-seq,所有小鼠均为C57Bl6/J背景。其中3只实验组和3只对照组接受1D11治疗,分别进行RNA-seq和Affy微阵列分析。
设计将8只实验组(Schistosoma诱导肺动脉高压)和8只对照组(无暴露)小鼠的全肺组织进行RNA-seq,所有小鼠均为C57Bl6/J背景。其中3只实验组和3只对照组接受1D11治疗,分别进行RNA-seq和Affy微阵列分析。
摘要Whole lung RNA-seq of 8 mice with experimental Schistosoma-induced pulmonary hypertension, compared to 8 control mice. All mice on a C57Bl6/J background. 3 schisto-PH and 3 control mice (#s 1-3 in each group) were also processed by Affy microarray and separately submitted. 3 of the mice in each group (labeled 1D11) were also treated with the pan-TGF-beta neutralizing antibody 1D11. Illumina HiSeq 2000 used. Data published in: Protective Role of IL6 in Vascular Remodeling in Schistosoma-Pulmonary Hypertension. Graham BB, Chabon J, Kumar R, Kolosionek E, Gebreab L, Debella E, Edwards M, Diener K, Shade T, Bifeng G, Bandeira A, Butrous G, Jones K, Geraci M, Tuder RM. Am J Respir Cell Mol Biol. 2013 Jul 1. [Epub ahead of print] PMID: 23815102
-
11 GSE216682 将Flk1-KO和control小鼠的内皮细胞分别在常氧和缺氧条件下培养,通过FACS分选后进行RNA测序,比较不同基因型在两种处理条件下的转录组差异。样本量按总单位数与组数估计,共12个样本。
设计将Flk1-KO和control小鼠的内皮细胞分别在常氧和缺氧条件下培养,通过FACS分选后进行RNA测序,比较不同基因型在两种处理条件下的转录组差异。样本量按总单位数与组数估计,共12个样本。
摘要To investigate the role of Flk1 in pulmonary arterial hypertension, we generated mice lacking Flk1 specifically in vascular endothelial cells. We exposed these mice to hypoxia and collected Flk1-KO endothelial cells by FACS for RNA-seq.
-
12 GSE278737 对SuHx诱导肺动脉高压模型小鼠及正常氧条件小鼠的肺驻留巨噬细胞和招募巨噬细胞进行基因表达检测,采用微阵列分析技术,比较不同处理条件与细胞类型组合下的基因表达差异。
设计对SuHx诱导肺动脉高压模型小鼠及正常氧条件小鼠的肺驻留巨噬细胞和招募巨噬细胞进行基因表达检测,采用微阵列分析技术,比较不同处理条件与细胞类型组合下的基因表达差异。
摘要We generated a Lineage tracing system to trace the fate of resident macrophages and recruited macrophages using GFP and RFP fluorescence respectively, in a SuHx-induced mouse PH model. Cx3cr1+GFP+resMФs and RFP+recMФs was achieved through bone marrow transplantation system and flow cytometry sorted. Gene-expression data was collected via microarray analysis.
-
13 GSE289897 对肺组织样本进行 bulk RNA 测序,比较 Tbx4 条件性敲除 (CKO) 小鼠与同源对照 (Tbx4fl/fl) 小鼠在出生后第 14 天 (P14) 和第 36 天 (P36) 的转录组差异,分析肺泡形成、血管化及血管重塑等发育特征。
设计对肺组织样本进行 bulk RNA 测序,比较 Tbx4 条件性敲除 (CKO) 小鼠与同源对照 (Tbx4fl/fl) 小鼠在出生后第 14 天 (P14) 和第 36 天 (P36) 的转录组差异,分析肺泡形成、血管化及血管重塑等发育特征。
摘要Pulmonary arterial hypertension (PAH) is a progressive vascular disease characterized by remodeling of the precapillary pulmonary arteries. Genomic variation within the T-box 4 (TBX4) transcription factor is the second most common genetic cause of PAH, and can also cause severe lung developmental disorders with neonatal PH. Currently, the effect of TBX4 loss-of-function on later stages of lung development and predisposition to lung disease, including PH, is not well understood. Therefore, we have generated Tbx4 conditional knockout (Tbx4-CKO) mice in which Cre recombinase deletes exon 5 of Tbx4 within the embryonic lung mesenchyme to create a null allele. We harvested lungs from these mice at various timepoints to examine alveologenesis, vascularization, vascular remodeling, lung cellular composition, and disruption of transcriptional activity compared with control lungs. Right ventricular systolic pressure (RVSP) was measured in six-month-old mice to evaluate for PH. Tbx4-CKO lungs show enlargement of airspaces, as confirmed by an increase in mean linear intercept at P14 (24.9%), P36 (31.5%), and P180 (49.6%). These lungs also show a 39.3% decrease in von Willebrand Factor-positive vessels and a 14.2% increase in vessel wall thickness. Consistent with these results, Tbx4-CKO mice show a statistically significant increase of 15.7% in RVSP and 16.3% in the Fulton index. Bulk-RNA sequencing analysis revealed enrichment of pathways and genes relevant to lung alveologenesis, angiogenesis, and PH. Our results show that disruption of Tbx4 expression during early lung development is sufficient to disrupt postnatal lung development and circulation.
-
14 GSE301479 将八周龄小鼠分为处理组(SU5416联合低氧)和对照组(DMSO联合正常氧),采集肺组织进行RNA-Seq,比较两组间PASMC反应差异。研究对象为ASMC-effector和NVSMC-effector小鼠系,分别通过Cspg4/Acta2和Chrm2/Acta2交差遗传学靶向血管SMCs(含PASMCs)及非血管SMCs(含BSMCs)。
设计将八周龄小鼠分为处理组(SU5416联合低氧)和对照组(DMSO联合正常氧),采集肺组织进行RNA-Seq,比较两组间PASMC反应差异。研究对象为ASMC-effector和NVSMC-effector小鼠系,分别通过Cspg4/Acta2和Chrm2/Acta2交差遗传学靶向血管SMCs(含PASMCs)及非血管SMCs(含BSMCs)。
摘要Previous studies to determine transcriptional changes in PASMCs during PAH were affected by the inevitable contamination with BSMCs and venous SMCs. To specific target ASMCs, we generated an ASMC-effector mouse line by combining Cspg4/Acta2 intersectional genetics, enabling specific targeting of vascular SMCs, including PASMCs. To target non-vascular SMCs, including BSMCs, we generated the NVSMC-effector mouse line using Chrm2/Acta2 intersectional genetics. The development of ASMC-effector mice, excluding venous and BSMCs, enabled us to avoid such problems and determine PASMC-specific reactions after induction of PAH.
-
15 GSE168159 将24只健康雄性C57/BL6小鼠分为常氧组、缺氧组和缺氧-常氧组,每组3个重复,采集肺组织总RNA进行lncRNA与mRNA微阵列分析,同步检测右心室收缩压(RVSP)等生理指标,比较三组间基因表达差异及生理参数变化。
设计将24只健康雄性C57/BL6小鼠分为常氧组、缺氧组和缺氧-常氧组,每组3个重复,采集肺组织总RNA进行lncRNA与mRNA微阵列分析,同步检测右心室收缩压(RVSP)等生理指标,比较三组间基因表达差异及生理参数变化。
摘要The potential roles of mRNAs and lncRNAs in the development and the reoxygenation treatment of reversal of hypoxic pulmonary hypertension are still unknown. 24 healthy adult male C57/BL6 mice were divided into three groups (normoxia group, hypoxia group, hypoxia-normoxia group), lncRNA and mRNA microarray was performed,meanwhile,the changes of right ven-tricular systolic pressure (RVSP) and other physiological indexes were measured in the three groups. The results showed that the index of RVSP, the right ventricular hypertrophy index RV/(LV+S), pulmonary artery walls and the muscularization ratio of pulmonary arterioles were significantly increased after Hypoxia treatment, while they were attenuated after the normoxia condition restored. Moreover, the study revealed there were 62 lncRNAs and 99 mRNAs with significant difference expression were associated with the reversal of hypoxic pulmonary hypertension by reoxygenation in mice. Furthermore, the pathway enrichment and gene ontology analysis of 99 DEGS were performed. Interestingly, the result suggested that chemokine subfamily CCL2/ CXCL played a role in the occurrence, development and reversion of pulmonary hypertension by reoxygenation. This study was the first time to demonstrate the transcriptome profiles of lncRNAs and mRNAs in the lung tissue during the reversal of hypoxic pulmonary hypertension in mice by reoxygenation, which might further broaden the understanding of the pathogenesis and the therapeutic effect of oxygen recovery of hypoxic pulmonary hypertension.
-
16 GSE180169 对小鼠肺内皮细胞进行 bulk RNA 测序,比较常氧对照组与 SU5416/慢性低氧诱导肺动脉高压模型组的转录组差异。从 Cdh5-CreERT2-TdTomato 小鼠中分离 TdTomato+内皮细胞,对照组 5 只小鼠维持常氧环境,PAH 组 4 只小鼠接受 3 周慢性低氧(10% O₂)处理并每周注射 SU5416(20 mg/kg)。RNA 提取采用 Qiagen miRNeasy Micro Kit,测序数据经 Trim Galore 质量控制处理,样本编号为 b-Cont1-5 和 b-PAH1-4。
设计对小鼠肺内皮细胞进行 bulk RNA 测序,比较常氧对照组与 SU5416/慢性低氧诱导肺动脉高压模型组的转录组差异。从 Cdh5-CreERT2-TdTomato 小鼠中分离 TdTomato+内皮细胞,对照组 5 只小鼠维持常氧环境,PAH 组 4 只小鼠接受 3 周慢性低氧(10% O₂)处理并每周注射 SU5416(20 mg/kg)。RNA 提取采用 Qiagen miRNeasy Micro Kit,测序数据经 Trim Galore 质量控制处理,样本编号为 b-Cont1-5 和 b-PAH1-4。
摘要Endothelial cell dysfunction plays a critical role in the development and pathogenesis of pulmonary arterial hypertension (PAH). We aimed to characterize the endothelial cell transcriptomic changes in PAH. We carried out bulk RNA sequencing of lung endothelial cells isolated from an endothelial cell lineage tracing mouse model in control and SU5416/Hypoxia-induced PAH conditions.
-
17 GSE261445 从 WT、Egln1Tie2Cre KO(CKO)及 Egln1Tie2Cre/Fabp4-5-/-(TKO)小鼠肺组织中提取总 RNA,采用 Illumina Novaseq 6000 平台进行 RNA 测序,每组包含 3 个独立重复样本。检测对象为肺动脉内皮细胞(PAECs)及肺组织,比较 WT、CKO 与 TKO 小鼠间 FABP4/5 表达差异。
设计从 WT、Egln1Tie2Cre KO(CKO)及 Egln1Tie2Cre/Fabp4-5-/-(TKO)小鼠肺组织中提取总 RNA,采用 Illumina Novaseq 6000 平台进行 RNA 测序,每组包含 3 个独立重复样本。检测对象为肺动脉内皮细胞(PAECs)及肺组织,比较 WT、CKO 与 TKO 小鼠间 FABP4/5 表达差异。
摘要Rationale: Pulmonary arterial hypertension (PAH) is a devastating disease characterized by obliterative vascular remodeling and persistent increase of vascular resistance, leading to right heart failure and premature death. Understanding the cellular and molecular mechanisms will help develop novel therapeutic approaches for PAH patients. Objectives: To determine whether upregulation of fatty-acid binding protein 4 and 5 (FABP4/5) is critical in pathogenesis of PAH. Methods: FABP4/5 expression was examined in pulmonary arterial endothelial cells (PAECs) and lung tissues from patients with idiopathic PAH and pulmonary hypertension (PH) rat models. Plasma proteome analysis was performed in human PAH samples. Echocardiography, hemodynamics, histology, and immunostaining were performed to evaluate the lung and heart PH phenotypes in Egln1Tie2Cre (CKO) mice and Egln1Tie2Cre/Fabp4-5-/- (TKO) mice. Measurement and Main Results: Both FABP4 and FABP5 were highly induced in ECs of CKO mice and PAECs from IPAH patients, and in whole lungs of PH rats. Plasma levels of FABP4/5 were upregulated in IPAH patients and directly correlated with severity of hemodynamics and biochemical parameters. Genetic deletion of both Fabp4 and 5 in CKO mice caused a reduction of right ventricular systolic pressure (RVSP) and RV hypertrophy, attenuated pulmonary vascular remodeling and prevented the right heart failure. Fabp4/5 deletion also normalized EC glycolysis, reduced ROS and HIF-2a expression, and decreased aberrant EC proliferation in CKO lungs. Conclusions: PH causes aberrant expression of FABP4/5 in pulmonary ECs which leads to enhanced EC glycolysis and hyperproliferation, contributing to the accumulation of arterial ECs and vascular remodeling and exacerbating the disease.
-
18 GSE61828 将8周龄C57BL/6小鼠分为Normoxia(对照)和hypoxia+SU5416诱导的肺动脉高压(PH)模型组,每组分别接受Short-NC或Short-130处理,每处理进行3次独立重复。采集肺组织进行RNA测序,比较PH模型组中Short-130处理与Short-NC处理的转录组差异。
设计将8周龄C57BL/6小鼠分为Normoxia(对照)和hypoxia+SU5416诱导的肺动脉高压(PH)模型组,每组分别接受Short-NC或Short-130处理,每处理进行3次独立重复。采集肺组织进行RNA测序,比较PH模型组中Short-130处理与Short-NC处理的转录组差异。
摘要Purpose: Guided by an in silico combination of microRNA (miRNA) target prediction, analysis of transcriptomic changes in 137 human diseases, and advanced gene network modeling, we predicted the miR-130/301 family of miRNAs as a shared regulator of a fibrotic gene network across human diseases, thus orchestrating broad control over disease manifestation. The goals of this study are to compare the lung mRNA profile of mouse model of Pulmonary hypertension, one of the most fibrotic pathology uncovered by our in silico prediction, treated with an inhibitor of miR-130/301 (Short-130) to mice treated with a control inhibitor (Short-NC). Methods: Eight-week-old mice (C57BL/6) were injected with SU5416 (20 mg/kg/dose; Sigma-Aldrich), followed by exposure to normobaric hypoxia (10% O2; OxyCycler chamber, Biospherix Ltd.) for 2 weeks. After 2 weeks and confirmation of PH development in 5 mice (right heart catheterization), mice were further treated with 3 intrapharyngeal injections (every 4 days) of control or miR-130/301 shortmer oligonucleotides, designed as fully modified antisense oligonucleotides complementary to the seed sequence of the miR-130/301 miRNA family (10 mg/kg/dose; Regulus). Specifically, the control and miR-130/301 shortmer oligonucleotides were nontoxic, lipid-permeable, high-affinity oligonucleotides. The miR-130/301 shortmer carried a sequence complementary to the active site of the miR-130/301 miRNA family, containing a phosphorothioate backbone and modifications (fluoro-, methoxyethyl, and bicyclic sugar) at the sugar 2’ position. Three days after the last injection, right heart catheterization was performed followed by harvesting of lung tissue for RNA extraction. Lung mRNA profiles of those mice or control mice (Normoxia+SU5416) were generated by deep sequencing, in triplicate, using Illumina HiSeq 2000. The sequence reads that passed quality filters were analyzed at the gene-level count. The gene level counts were then normalized with the R/Bioconductor package limma using the voom /variance stabilization method. The data were quality controlled for outliers using principal component analysis (PCA). Differential expression analysis between transcriptome profiles of experimental groups was performed using the R / Bioconductor package limma. Results: Transcriptomic analyses of whole lung from mice with hypoxia+SU5416-induced PH revealed a generalized de-repression of miR-130/301 targets by Short-130 treatment. Importantly, although whole lung transcriptomics likely captured only a subset of the miR-130/301 targets affecting the diseased pulmonary vasculature, pathway enrichment nonetheless revealed pronounced representation of several pathways known to be involved in fibrosis. Thus, the miR-130/301 family indeed induces a programmatic shift at the molecular level toward the fibrotic pathophenotype in vivo
-
19 GSE21583 将三只雌性FVB/N小鼠按 Rosa26-rtTA2 转基因状态(+/-)与 BMPR2-R899X 转基因状态(+/-)组合分组,每组接受或未接受重组人ACE2渗透泵输注,各组样本为全肺匀浆液混池,采集总RNA进行微阵列表达分析,比较不同转基因组合与ACE2处理间的基因表达差异。
设计将三只雌性FVB/N小鼠按 Rosa26-rtTA2 转基因状态(+/-)与 BMPR2-R899X 转基因状态(+/-)组合分组,每组接受或未接受重组人ACE2渗透泵输注,各组样本为全肺匀浆液混池,采集总RNA进行微阵列表达分析,比较不同转基因组合与ACE2处理间的基因表达差异。
摘要BMPR2 mutation causes pulmonary arterial hypertension (PAH); ACE2 treatment can resolve established BMPR2-mediated PAH. The purpose of this study was to uncover the molecular mechanism behind this.
-
20 GSE11018 将FVB/N小鼠分为对照组(仅SM22-rtTA转基因)和BMPR2-R899X突变组(进一步分为RVSP正常与RVSP升高),每组2只,自4周龄起持续喂食doxycycline 9周后处死,采集全肺匀浆进行基因表达分析,比较不同基因型与处理状态下的转录组差异。
设计将FVB/N小鼠分为对照组(仅SM22-rtTA转基因)和BMPR2-R899X突变组(进一步分为RVSP正常与RVSP升高),每组2只,自4周龄起持续喂食doxycycline 9周后处死,采集全肺匀浆进行基因表达分析,比较不同基因型与处理状态下的转录组差异。
摘要Familial pulmonary arterial hypertension (fPAH) is associated with mutations in BMPR2. Many of these mutations occur in the BMPR2 tail domain, leaving the SMAD functions intact. In order to determine the in vivo consequences of BMPR2 tail domain mutation, we created a smooth-muscle specific doxycycline inducible BMPR2 mutation with an arginine to termination mutation at amino acid 899. When these SM22-rtTA x TetO7-BMPR2R899X mice had transgene induced for 9 weeks, starting at 4 weeks of age, they universally developed pulmonary vascular pruning as assessed by fluorescent microangiography. Approximately half the time the induced animals developed elevated right ventricular systolic pressures (RVSP), associated with extensive pruning, muscularization of small pulmonary vessels, and development of large structural pulmonary vascular changes. These lesions included large numbers of macrophages and T-cells in their adventitial compartment, as well as CD133 positive cells in the lumen. Small vessels filled with CD45 positive and sometimes CD3 positive cells were a common feature in all SM22-rtTA x TetO7-BMPR2R899X mice. Gene array experiments show changes in stress response, muscle organization and function, proliferation and apoptosis, and developmental pathways before RVSP increases. Our results show that the primary phenotypic result of BMPR2 tail domain mutation in smooth muscle is pulmonary vascular pruning leading to elevated RVSP, associated with early dysregulation in multiple pathways with clear relevance to PAH. This model should be useful to the research community in examining early molecular and physical events in the development of PAH, and as a platform to validate potential treatments. Keywords: Disease state analysis
-
21 GSE128358 将C57BL/6小鼠分为对照组(每周注射0.2mL生理盐水)、MCT组(每周注射0.1mL MCT)和MCT-C75组(每周注射0.1mL MCT及0.1mL C75),持续5周后采集肺组织进行RNA-Seq,比较三组间mRNA与lncRNA的表达差异。
设计将C57BL/6小鼠分为对照组(每周注射0.2mL生理盐水)、MCT组(每周注射0.1mL MCT)和MCT-C75组(每周注射0.1mL MCT及0.1mL C75),持续5周后采集肺组织进行RNA-Seq,比较三组间mRNA与lncRNA的表达差异。
摘要Investigated the expression profile and potential roles of mRNA and long non-coding RNAs (lncRNAs) in pulmonary arterial hypertension (PAH) mice induced by monocrotaline.
-
22 GSE193272 将8周龄雄性C57BL6小鼠肺组织中分离的内皮细胞分为缺氧3周处理组与常氧对照组,每组取3只小鼠混池样本进行RNA测序,比较两组间基因表达差异。研究对象为肺内皮细胞,检测方式为RNA-Seq,使用STAR算法进行基因组比对和表达计数,样本来源为小鼠肺组织。
设计将8周龄雄性C57BL6小鼠肺组织中分离的内皮细胞分为缺氧3周处理组与常氧对照组,每组取3只小鼠混池样本进行RNA测序,比较两组间基因表达差异。研究对象为肺内皮细胞,检测方式为RNA-Seq,使用STAR算法进行基因组比对和表达计数,样本来源为小鼠肺组织。
摘要Uncontrolled accumulation of pulmonary artery smooth muscle cells (PASMC) to the non-muscularized distal pulmonary arterioles (PAs) is one of the major characteristics of pulmonary hypertension (PH). Cellular senescence contributes to aging and lung diseases associated with PH and links to PH progression. However, the mechanism by which cellular senescence controls vascular remodeling in PH is not fully understood. Here, we have demonstrated that endothelial senescence mediates PH pathology by increasing platelet-derived growth factor (PDGFB) expression. The levels of senescence markers p16INK4A and senescence-associated β-galactosidase (SA-β-gal) are higher in PA endothelial cells (ECs) isolated from IPAH patients compared to those from healthy individuals. Hypoxia-induced accumulation of α-smooth muscle actin (αSMA)-positive cells to the PAs is attenuated in p16INK4Afl/fl-Cdh5(PAC)-CreERT2 mice after tamoxifen induction. We have reported that endothelial TWIST1 mediates hypoxia-induced vascular remodeling by increasing PDGFB expression. Transcriptomic analyses of idiopathic pulmonary arterial hypertension (IPAH) patient lung ECs or hypoxia-induced mouse lung ECs reveal the alteration of senescence-related gene expression and interaction with TWIST1. Increases in the levels of PDGFB and TWIST1 in hypoxia-treated mouse lung ECs or IPAH patient lung ECs are attenuated by knocking down p16INK4A expression or treating with senolytic reagents. Knockdown of p16INK4A also suppresses accumulation of αSMA–positive cells to the supplemented ECs in the gel. Exosomes collected from hypoxia-treated mouse lung ECs stimulate SMC DNA synthesis and migration in vitro and in the gel implanted on the mouse lungs, while p16INK4A knockdown in ECs inhibits the effects. These results suggest that endothelial senescence controls αSMA–positive cell proliferation and migration in PH through TWIST1-PDGFB signaling.
-
23 GSE23178 对肺动脉高压模型小鼠与正常对照小鼠的肺组织进行基因表达检测,比较两组间差异。PAH模型组小鼠接受重复气管内注射Stachybotrys chartarum孢子处理,正常对照组注射RPMI-1636培养基。每组取3只小鼠,采集肺组织后提取总RNA,通过GeneChip® 3' IVT Express Kit制备RNA靶标,合成标记生物素的aRNA并杂交至Mouse Genome 430 2.0 Array芯片。
设计对肺动脉高压模型小鼠与正常对照小鼠的肺组织进行基因表达检测,比较两组间差异。PAH模型组小鼠接受重复气管内注射Stachybotrys chartarum孢子处理,正常对照组注射RPMI-1636培养基。每组取3只小鼠,采集肺组织后提取总RNA,通过GeneChip® 3' IVT Express Kit制备RNA靶标,合成标记生物素的aRNA并杂交至Mouse Genome 430 2.0 Array芯片。
摘要It has been reported that repeated intra-tracheal instillation of S. chartarum spores induced significant pulmonary arterial remodeling in mice, which resulted in pathological changes like human pulmonary arterial hypertension (PAH) and elevation right ventricle systolic pressure. Then, we used microarrays to know the complex molecular mechanisms that underlie pathogenesis of PAH.
-
24 GSE296956 对4个月龄TNF-Tg转基因小鼠与野生型小鼠肺组织进行bulk RNA-seq测序,比较两组间基因表达差异。样本按3个独立重复分别采集,使用QIAGEN Rneasy Plus试剂盒提取总RNA,未提及混池方式。
设计对4个月龄TNF-Tg转基因小鼠与野生型小鼠肺组织进行bulk RNA-seq测序,比较两组间基因表达差异。样本按3个独立重复分别采集,使用QIAGEN Rneasy Plus试剂盒提取总RNA,未提及混池方式。
摘要Recently, we found that human TNF transgenic (TNF-Tg) mice died by 6-month from cardiopulmonary disease. Histological analysis showed that TNF-Tg mice were characterized by the pulmonary vascular and right ventricular pathology. This pathology closely mimics human connective tissue disease (CTD) associated pulmonary arterial hypertension (PAH). In this study, we aimed to investigate the gene expression in TNF-Tg lung using bulkRNA-seq technology.
-
25 GSE48936 将3只实验性Schistosoma诱导肺动脉高压小鼠与3只对照小鼠的全肺组织进行转录组分析,比较两组基因表达差异。对照组未接受处理,实验组通过腹腔注射和尾静脉注射给予240 S. mansoni卵,1周后采集组织。采用Affymetrix Mouse Gene 1.0 ST Array平台检测总RNA表达,数据经GC-RMA算法预处理。
设计将3只实验性Schistosoma诱导肺动脉高压小鼠与3只对照小鼠的全肺组织进行转录组分析,比较两组基因表达差异。对照组未接受处理,实验组通过腹腔注射和尾静脉注射给予240 S. mansoni卵,1周后采集组织。采用Affymetrix Mouse Gene 1.0 ST Array平台检测总RNA表达,数据经GC-RMA算法预处理。
摘要Rationale: Schistosomiasis is one of the most common causes of pulmonary arterial hypertension worldwide, but the pathogenic mechanism by which the host inflammatory response contributes to vascular remodeling is unknown. We sought to identify signaling pathways that play protective or pathogenic roles in experimental Schistosoma-induced pulmonary vascular disease by whole-lung transcriptome analysis. Methods: Wildtype mice were experimentally exposed to S. mansoni ova by intraperitoneal sensitization followed by tail vein augmentation, and the phenotype assessed by right ventricular catheterization and tissue histology, RNA and protein analysis. Whole-lung transcriptome analysis by microarray and RNA sequencing was performed, the latter analyzed using 2 bioinformatic methods. Functional testing of the candidate IL-6 pathway was determined using IL6-knockout mice and the STAT3 inhibitor STI-201. Results: Wild-type mice exposed to S. mansoni had increased right ventricular systolic pressure and thickness of the pulmonary vascular media. Whole lung transcriptome analysis identified the IL6-STAT3-NFATc2 pathway as being upregulated, which was confirmed by PCR and immunostaining of lung tissue from S. mansoni-exposed mice and patients who died of the disease. Mice lacking IL6 or treated with STI-201 developed pulmonary hypertension associated with significant intima remodeling after exposure to S. mansoni. Conclusions: Whole lung transcriptome analysis identified upregulation of the IL6-STAT3-NFATc2 pathway, and IL6 signaling was found to be protective against Schistosoma-induced intimal remodeling. Affy Mouse ST1.0 chip used. Data published in: Protective Role of IL6 in Vascular Remodeling in Schistosoma-Pulmonary Hypertension. Graham BB, Chabon J, Kumar R, Kolosionek E, Gebreab L, Debella E, Edwards M, Diener K, Shade T, Bifeng G, Bandeira A, Butrous G, Jones K, Geraci M, Tuder RM. Am J Respir Cell Mol Biol. 2013 Jul 1. [Epub ahead of print] PMID: 23815102
大鼠单细胞
Rat · Single-cell
-
01 GSE330160 本研究使用sugen-缺氧大鼠模型评估抗降解apelin类似物对肺动脉高压的治疗效果。将野生型Sprague-Dawley大鼠分为常氧对照组、缺氧诱导肺动脉高压组及缺氧诱导肺动脉高压并给予apelin类似物处理组,采集肺和右心室组织进行单核RNA测序,比较各组间转录特征差异。
设计本研究使用sugen-缺氧大鼠模型评估抗降解apelin类似物对肺动脉高压的治疗效果。将野生型Sprague-Dawley大鼠分为常氧对照组、缺氧诱导肺动脉高压组及缺氧诱导肺动脉高压并给予apelin类似物处理组,采集肺和右心室组织进行单核RNA测序,比较各组间转录特征差异。
摘要Pulmonary arterial hypertension (PAH) is a progressive disease marked by pulmonary vascular remodeling, elevated pulmonary pressures, and right ventricular (RV) failure. In this study, a sugen-hypoxia rat model of PAH was used to evaluate a novel, degradation-resistant apelin analog targeting the apelinergic pathway, which is implicated in pulmonary vascular remodeling. Treatment with the apelin analog reversed key pathological features of PAH, including pulmonary vascular lesions, elevated pulmonary arterial pressures, RV dilation and dysfunction, and early cardiorenal syndrome. The therapy also reduced RV cardiomyocyte and fibroblast activation caused by pressure overload. Single-nucleus RNA sequencing of the lungs and RV demonstrated that apelin analog treatment activated protective molecular programs, notably restoring balance between protective BMPR2 signaling and pathogenic TGFBR2 signaling. Overall, these findings suggest that exogenous apelin therapy may represent a promising strategy to reverse pulmonary vascular and cardiac remodeling in PAH and warrants further clinical investigation.
-
02 GSE297371 将Sprague-Dawley大鼠肺内皮细胞核在对照组与三个时间点(1、2、3周)的SuHx处理条件下进行单细胞多组学分析,采用10x Genomics Chromium Next GEM平台同步检测基因表达与染色质可及性,比较不同处理阶段的转录组与表观组差异。
设计将Sprague-Dawley大鼠肺内皮细胞核在对照组与三个时间点(1、2、3周)的SuHx处理条件下进行单细胞多组学分析,采用10x Genomics Chromium Next GEM平台同步检测基因表达与染色质可及性,比较不同处理阶段的转录组与表观组差异。
摘要Background: Pulmonary arterial hypertension (PAH) is a debilitating disease with a poor prognosis. However, only a limited number of palliative interventions are currently available. To address this unmet need, it is essential to understand the molecular etiology of PAH by identifying unique disease-associated populations and their key molecular regulators during the progression of the disease. Methods: We constructed a single-cell multiome dataset at four distinct time points during the pathogenesis of pulmonary hypertension (PH) using endothelial cells (ECs) isolated from the Sugen5416/Hypoxia rat model. We assessed conservation of novel disease-associated ECs by reanalyzing previously reported scRNA-seq data from human PAH patients. We validated the functional importance of EBF1 in PAH by performing in silico simulations and a pulmonary endothelium-targeting AAV-mediated in vivo knockdown. Results: We found that progression of PH gradually altered the transcriptional and epigenetic landscape in pulmonary endothelium in a stage-specific manner, leading to the emergence of a novel disease-associated arterial endothelial population expressing EBF1. A similar endothelial subset was present in human PAH patients. Immunofluorescence revealed that EBF1 expression was elevated in both human and rat lungs during the progression of PH. In silico simulations suggested EBF1 is required for the pathogenic state, and the AAV-mediated in vivo knockdown of Ebf1 ameliorated the pathological hallmarks of PH, including right ventricular systolic pressure and right ventricular hypertrophy, when delivered either prior to the onset or even after the establishment of PH. Conclusions: We identified EBF1 as a key transcriptional regulator of a novel disease-associated population in both humans and rats. We further demonstrated that inhibiting EBF1 within the pulmonary endothelium ameliorates the pathological features of PH, suggesting that EBF1 and its transcriptional targets represent a novel and promising therapeutic avenue for PAH.
-
03 GSE307675 对肺动脉高压模型大鼠的离散肺细胞进行单细胞 RNA 测序,分别在第 1、3、5、8 周及健康对照组采集样本,比较不同时间点与健康对照的转录组变化,以识别与阻塞性动脉重塑相关的疾病特异性血管细胞群体。
设计对肺动脉高压模型大鼠的离散肺细胞进行单细胞 RNA 测序,分别在第 1、3、5、8 周及健康对照组采集样本,比较不同时间点与健康对照的转录组变化,以识别与阻塞性动脉重塑相关的疾病特异性血管细胞群体。
摘要Pulmonary arterial hypertension (PAH) is a lethal pulmonary vascular disease characterized by arteriolar pruning and occlusive vascular remodeling leading to increased pulmonary vascular resistance and eventually right heart failure. While endothelial cell (EC) injury and apoptosis are known triggers for this disease, the mechanisms by which they lead to complex arterial remodeling remain obscure. Aims: We employed multiplexed single-cell RNA sequencing at multiple timepoints during the onset and progression of disease in a model of severe PAH to identify mechanisms involved in the development of occlusive arterial lesions. Methods and Results: Single cell transcriptional analysis resolved 44 global lung cell populations, with widespread early transcriptomic changes at 1 week affecting endothelial, stromal and immune cell populations. In particular, two EC clusters were greatly expanded during PAH development and were identified as being disease specific: a relatively dedifferentiated (dD) EC population that was enriched for Cd74 expression while exhibiting a loss of endothelial identity; and an activated arterial EC (aAEC) population that uniquely exhibited persistent differential gene expression throughout PAH development consistent with a growth regulated state. dDECs were primed to undergo endothelial-mesenchymal transition as evidenced by reduced activity of master EC transcription factors, Erg and Fli1, and further supported by RNA velocity analysis showing vectors leading to fibroblast clusters. Of note, aAECs exhibited high expression of Tm4sf1, a gene implicated in cancer cell growth, that was also expressed by a smooth muscle (SM)-like pericyte cluster, and were highly localized to regions of arterial remodeling in both the rat model and PAH patients, contributing to intimal occlusive lesions and SM-like pericytes forming bands of medial muscularization. Conclusions: Together these findings implicate disease-specific vascular cells in PAH progression and suggest that TM4SF1 may be a novel therapeutic target for arterial remodeling. Translational Perspectives: Using single cell transcriptomic analysis in both human lung samples and a rat model of severe PAH we have identified disease-specific EC populations contributing to complex arterial remodeling, including growth-dysregulated, activated arterial ECs (aAECs) and dedifferentiated ECs (dDECs) that may be primed for endothelial to mesenchymal transition. In particular, aAECs exhibit high expression of a surface marker, TM4SF1, which is essential for their hyper-proliferative phenotype and represents a promising therapeutic target for RNA silencing approaches or as an antigen to guide immune-mediated ablation of this cancer-like EC population in PAH.
-
04 GSE247625 Focused ultrasound of the spleen is an emerging therapeutic modality and recent reports have shown efficacy in reducing inflammation. We used scRNA seq to identify the gene expression changes in lungs of healthy animals, animals with pulmonary hypertension treated with focused ultrasound of the spleen or sham stimulation.
摘要Focused ultrasound of the spleen is an emerging therapeutic modality and recent reports have shown efficacy in reducing inflammation. We used scRNA seq to identify the gene expression changes in lungs of healthy animals, animals with pulmonary hypertension treated with focused ultrasound of the spleen or sham stimulation.
大鼠bulk 转录组
Rat · Bulk RNA-seq
-
01 GSE149899 将肺动脉高压(PAH)诱导的肺组织(Reversible PAH、Irreversible PAH)与正常对照肺组织分别在LTx前采集,通过RNA-seq比较三组肺组织的转录组差异。PAH模型通过60mg/kg MCT注射联合主动脉-腔静脉分流术建立,LTx操作在MCT注射后第14、21或28天进行。所有样本为大鼠右上叶肺组织,RNA提取采用3个生物重复,每个重复取500ng总量。研究包含3种疾病状态(Control、Reversible PAH、Irreversible PAH)和4个时间点(14、21、27、28天),其中Reversible PAH组N=11,Irreversible PAH组N=7,Control组N=5。
设计将肺动脉高压(PAH)诱导的肺组织(Reversible PAH、Irreversible PAH)与正常对照肺组织分别在LTx前采集,通过RNA-seq比较三组肺组织的转录组差异。PAH模型通过60mg/kg MCT注射联合主动脉-腔静脉分流术建立,LTx操作在MCT注射后第14、21或28天进行。所有样本为大鼠右上叶肺组织,RNA提取采用3个生物重复,每个重复取500ng总量。研究包含3种疾病状态(Control、Reversible PAH、Irreversible PAH)和4个时间点(14、21、27、28天),其中Reversible PAH组N=11,Irreversible PAH组N=7,Control组N=5。
摘要PAH was induced by 60mg/kg MCT and an aorto-caval shunt. At different timepoints of PAH progression (day 14, 21 and 28 after MCT-injection), the left lung with PAH was hemodynamically unloading by unilateral orthotopic transplatation into a syngeneic, healthy recipient. All day 14 and 7/10 day 21 transplanted lungs showed reversal of PAH after LTx. All day 28 and 3/10 day 21 transplanted lungs showed PAH progression after LTx. Lung tissue of Reversible and Irreversible PAH and normal controls, acquired at LTx, was compared using RNA-seq.
-
02 GSE8134 将Dahl Salt-Sensitive大鼠分为5组:normoxia/vehicle(Norm)、hypoxia/vehicle(H)、hypoxia/SU5416(H-SU)、hypoxia/Sorafenib(H-Sor)和hypoxia/SU5416/Sorafenib(H-SU-Sor),除Norm组外均置于FiO2为10%的低氧舱中。H组单次注射SU5416(20 mg/kg)于第1天,H-Sor组每日灌胃Sorafenib(2.5 mg/kg)持续3.5周。实验结束后通过开胸导管测量肺血管和右心室压力,采集肺和心脏组织进行组织学及微阵列分析。H-SU组与H组相比,H-SU-Sor组与H-SU组分别比较基因表达差异,采用R软件 normalization 和SAM算法(δ>.639,最小倍数变化>1.4)分析H(n=4)和H-SU(n=3)肺组织与Norm(n=4)的表达差异,同时对H-SU与H-SU-Sor组(n=4)进行独立比较。
设计将Dahl Salt-Sensitive大鼠分为5组:normoxia/vehicle(Norm)、hypoxia/vehicle(H)、hypoxia/SU5416(H-SU)、hypoxia/Sorafenib(H-Sor)和hypoxia/SU5416/Sorafenib(H-SU-Sor),除Norm组外均置于FiO2为10%的低氧舱中。H组单次注射SU5416(20 mg/kg)于第1天,H-Sor组每日灌胃Sorafenib(2.5 mg/kg)持续3.5周。实验结束后通过开胸导管测量肺血管和右心室压力,采集肺和心脏组织进行组织学及微阵列分析。H-SU组与H组相比,H-SU-Sor组与H-SU组分别比较基因表达差异,采用R软件 normalization 和SAM算法(δ>.639,最小倍数变化>1.4)分析H(n=4)和H-SU(n=3)肺组织与Norm(n=4)的表达差异,同时对H-SU与H-SU-Sor组(n=4)进行独立比较。
摘要Pulmonary hypertension (PH) and cancer pathophysiology share common signal transduction pathways leading to abnormal endothelial and smooth muscle cell interactions and angioproliferative vasculopathy. Sorafenib (Sor) a drug in clinical trials for cancer treatment, is an inhibitor of multiple kinases important in angiogenesis (Raf-1 kinase, VEGFR-2, VEGFR-3, PDGFR-beta). In this study, we assessed the efficacy of Sor as a potential therapy for PH, and hypothesized that Sor prevents the development of both a conventional and an augmented rodent model of PH. We performed studies in Dahl Salt-Sensitive rats (SS) exposed to hypoxia alone and in combination with the VEGFR-2 inhibitor, SU5416, known to induce a well-characterized augmented PH phenotype. Rats were, thus, divided into 5 groups: normoxia/vehicle (Norm), hypoxia/vehicle (H), hypoxia/ SU5416 (H-SU), hypoxia/Sorafenib (H-Sor) and hypoxia/ SU5416/ Sorafenib (H-SU-Sor). Except for the Norm group, all rats were maintained in a hypoxia chamber with a FiO2 of 10%. Rats received a single injection of SU5416 on Day 1 (20 mg/kg) and Sor solution was administered daily by gavage (2.5mg/kg). After 3.5 weeks, all rats were assessed by open chest catheterizations for pulmonary vascular and right ventricular pressures. Lung and heart tissue were harvested for histological and microarray analyses. Our results showed H-SU rats developed severe PH with changes in hemodynamic and histologic parameters when compared to Norm controls while rats exposed to H alone only displayed mildly elevated pressures compared with Norm. There was no significant change in pressures in the H-Sor or H-SU-Sor compared to Norm. Histopathology demonstrated a dramatic prevention of the PH phenotype in the H-SU-Sor rats with no significant remodeling compared with H-SU rats. Expression profiling data from H (n=4) and H-SU (n=3) rat lungs were compared to Norm (n=4) using normalization in R and SAM (δ>.639,) (minimum fold change >1.4). With false discovery rates (FDR) of 6.5% in hypoxia and 1.6% in H-SU, 1019 and 465 genes, respectively, were differentially-regulated compared to Norm. In addition, 38 genes were differentially expressed between H-SU and H-SU-Sor (n=4, FDR 6.7%) revealing a molecular signature with potentially novel target genes of Sor. Five differentially expressed genes (Tgfbeta3, C1qg, Nexn, Frzb, and Plaur) were examined by real-time RT-PCR and three were further validated by immunohistochemistry confirming the regulation on protein level. Based on the known pathways of hypoxic-induced PH and Sor, we further utilized immunohistochemistry to show the up-regulation of mediators of the MAPK cascade in the H and H-SU models of PH with subsequent, down-regulation by Sor. We therefore present Sor as a novel treatment for the development of severe PH and theorize that the MAPK cascade is a canonical pathway involved both in the development of PH and in the attenuation by Sor. This SuperSeries is composed of the SubSeries listed below.
-
03 GSE149713 对肺动脉高压模型大鼠与对照组大鼠的肺组织进行RNA测序,比较不同时间点的转录组差异。对照组大鼠在处理前(week 0)及处理后第1、2、3、4周分别处死,MCT处理组大鼠在处理后第1、2、3、4周处死,每组处理时间点样本数为3只,对照组样本数为5只。
设计对肺动脉高压模型大鼠与对照组大鼠的肺组织进行RNA测序,比较不同时间点的转录组差异。对照组大鼠在处理前(week 0)及处理后第1、2、3、4周分别处死,MCT处理组大鼠在处理后第1、2、3、4周处死,每组处理时间点样本数为3只,对照组样本数为5只。
摘要Inflammation and immunity play a causal role in the pathogenesis of pulmonary vascular remodeling and pulmonary arterial hypertension (PAH). However, the pathways and mechanisms by which inflammation and immunity contribute to pulmonary vascular remodeling remain unknown. RNA sequencing was used to analyze the transcriptome in control and rats injected with monocrotaline (MCT) for 1, 2, 3 and 4 weeks. Using the transcriptional profiling of MCT-induced PAH coupled with bioinformatics analysis, we clustered the differentially expressed genes (DEGs) and chose the increased expression patterns associated with inflammatory and immune response. We found the enrichment of Toll-like receptor (TLR) and NOD-like receptor (NLR) pathways and identified NF-κB-mediated inflammatory and immune profiling in MCT-induced PAH. Pathway-based data integration and visualization showed the dysregulated TLR and NLR pathways, including increased expression of TLR2 and NLRP3, and their downstream molecules. Further analysis revealed that the activation of TLR and NLR pathways was associated with upregulation of damage-associated molecular patterns (DAMPs) and RIPK3-mediated necroptosis was involved in the generation of DAMPs in MCT-induced PAH. Collectively, we identify RIPK3-mediated necroptosis and its triggered TLR and NLR pathways in the progression of pulmonary vascular remodeling, thus, providing novel insights into the mechanisms underlying inflammation and immunity in the pathogenesis of PAH.
-
04 GSE186996 Pulmonary arterial hypertension (PAH) is a debilitating progressive disease characterized by high blood pressure in the pulmonary artery. Chrysin (5,7-dihydroxyflavone) is a phytochemical, which is a flavonoid widely present in plant sources. It is known that right ventricular dysfunction is the worst mortality predictor in patient with PAH. Recent studies have shown that chrysin improves hemodynamic parameters including right ventricular pressure, right ventricular hypertrophy, and pulmonary vascular remodeling in a rat model of chronic hypoxia-induced pulmonary hypertension. On the other hand, trimetazidine (TMZ) is an anti-ischemic agent widely used in the treatment of coronary artery disease. It has been reported that trimetazidine therapy for 3 months on top of standard PAH regime significantly improve right ventricular ejection fraction and functional capacity in patient with PAH. However, the effects of chrysin or trimetazidine on gene expression in lung of patient with PAH. Here, we performed that a comprehensive analysis of gene expression changes in lung tissues of sugen-received rats under hypoxic conditions, which is a model of PAH with chrysin or trimetazidine treatment using RNA sequencing (RNA-seq).
摘要Pulmonary arterial hypertension (PAH) is a debilitating progressive disease characterized by high blood pressure in the pulmonary artery. Chrysin (5,7-dihydroxyflavone) is a phytochemical, which is a flavonoid widely present in plant sources. It is known that right ventricular dysfunction is the worst mortality predictor in patient with PAH. Recent studies have shown that chrysin improves hemodynamic parameters including right ventricular pressure, right ventricular hypertrophy, and pulmonary vascular remodeling in a rat model of chronic hypoxia-induced pulmonary hypertension. On the other hand, trimetazidine (TMZ) is an anti-ischemic agent widely used in the treatment of coronary artery disease. It has been reported that trimetazidine therapy for 3 months on top of standard PAH regime significantly improve right ventricular ejection fraction and functional capacity in patient with PAH. However, the effects of chrysin or trimetazidine on gene expression in lung of patient with PAH. Here, we performed that a comprehensive analysis of gene expression changes in lung tissues of sugen-received rats under hypoxic conditions, which is a model of PAH with chrysin or trimetazidine treatment using RNA sequencing (RNA-seq).
-
05 GSE72707 对成年雄性 Sprague-Dawley 大鼠肺组织进行基因表达分析,设置正常大气条件(无 MCT)与缺氧条件(无 MCT)两组对照,同时分别给予 MCT 处理。共包含四个处理组合:正常大气无 MCT(CO)、缺氧无 MCT(HO)、正常大气有 MCT(CM)、缺氧有 MCT(HM),每个组合包含 4 个生物复制品。通过比较不同处理条件下的基因表达差异,分析 MCT 与缺氧联合处理对肺动脉高压相关转录组的影响。
设计对成年雄性 Sprague-Dawley 大鼠肺组织进行基因表达分析,设置正常大气条件(无 MCT)与缺氧条件(无 MCT)两组对照,同时分别给予 MCT 处理。共包含四个处理组合:正常大气无 MCT(CO)、缺氧无 MCT(HO)、正常大气有 MCT(CM)、缺氧有 MCT(HM),每个组合包含 4 个生物复制品。通过比较不同处理条件下的基因表达差异,分析 MCT 与缺氧联合处理对肺动脉高压相关转录组的影响。
摘要Pulmonary hypertension (PH), a rare disorder is a complication of a number of cardiopulmonary, unrelated systemic diseases, drug toxicity and genetic mutations. Major advances have been made in the field, but the pathogenesis of PH is not yet understood. Several experimental models such as monocrotaline (MCT) and hypoxia have been used to understand the mechanism underlying the pathogenesis of PH. We have recently shown that that the addition of hypoxia to MCT injected rats accelerates the disease process leading to neointima formation. We have profiled the lungs of adult male Sprague-Dawley rats kept for 4 weeks in normal atmospheric conditions or in hypobaric hypoxia (380 mmHg) w/o subcutaneous injection with 40 mg/kg MCT or just saline. While MCT and hypoxia altered expression of few genes when applied separately, together they induced a substantial alteration of the transcriptome. The most profoundly altered pathways by the combined effect of hypoxia and MCT were: endocytosis, apoptosis, HIF-1 signaling pathway and vascular smooth muscle contraction.
-
06 GSE85618 对肺动脉高压大鼠肺组织进行微阵列分析,比较缺氧未处理组、E2处理组(75 mcg/kg/d)、E2+fulvestrant处理组及常氧对照组的基因表达差异。采用RMA算法处理CEL文件,生成标准化信号并进行log2转换。每组包含4只雄性Sprague-Dawley大鼠,通过皮下泵持续给药三周,随后暴露于缺氧环境两周。实验包含16个GSM样本,未提及混池方式。
设计对肺动脉高压大鼠肺组织进行微阵列分析,比较缺氧未处理组、E2处理组(75 mcg/kg/d)、E2+fulvestrant处理组及常氧对照组的基因表达差异。采用RMA算法处理CEL文件,生成标准化信号并进行log2转换。每组包含4只雄性Sprague-Dawley大鼠,通过皮下泵持续给药三周,随后暴露于缺氧环境两周。实验包含16个GSM样本,未提及混池方式。
摘要17β-estradiol (E2) exerts complex and context-dependent effects in pulmonary hypertension. In hypoxia-induced pulmonary hypertension (HPH), E2 attenuates lung vascular remodeling through estrogen receptor (ER)-dependent effects; however, ER target genes in the hypoxic lung remain unknown. In order to identify the genome regulated by the E2-ER axis in the hypoxic lung, we performed a microarray analysis in lungs from HPH rats treated with E2 (75 mcg/kg/d) ± ER-antagonist ICI182,780 (3 mg/kg/d). Untreated HPH rats and normoxic rats served as controls. Using a false discovery rate of 10%, we identified a significantly differentially regulated genome in E2-treated vs. untreated hypoxia rats. Genes most up-regulated by E2 encoded matrix metalloproteinase 8, S100 calcium binding protein A8, and IgA Fc receptor; genes most down-regulated by E2 encoded olfactory receptor 63, secreted frizzled-related protein 2, and thrombospondin 2. Several genes affected by E2 changed in the opposite direction after ICI182,780 co-treatment, indicating an ER-regulated genome in HPH lungs. The bone morphogenetic protein antagonist Grem1 (gremlin 1) was up-regulated by hypoxia, but found to be among the most down-regulated genes after E2 treatment. Gremlin 1 protein was reduced in E2-treated vs. untreated hypoxic animals, and ER-blockade abolished the inhibitory effect of E2 on Grem1 mRNA and protein. In conclusion, E2 ER-dependently regulates several genes involved in proliferative and inflammatory processes during hypoxia. Gremlin 1 is a novel target of the E2-ER axis in HPH. Understanding the mechanisms of E2 gene regulation in HPH may allow for selectively harnessing beneficial transcriptional activities of E2 for therapeutic purposes.
-
07 GSE160926 将大鼠分为四个组,分别接受常氧(N)、缺氧(H)、缺氧加连续3小时再氧合(C3)和缺氧加间歇性3小时再氧合(I3)处理,经过2周处理后采集肺组织进行RNA测序,比较各组间基因表达差异。
设计将大鼠分为四个组,分别接受常氧(N)、缺氧(H)、缺氧加连续3小时再氧合(C3)和缺氧加间歇性3小时再氧合(I3)处理,经过2周处理后采集肺组织进行RNA测序,比较各组间基因表达差异。
摘要High-altitude pulmonary hypertension (HAPH) is a severe and progressive disease caused by chronic hypoxia and subsequent pulmonary vascular remodeling. No cure is currently available owing to an incomplete understanding about vascular remodeling. It is believed that hypoxia-induced diseases can be prevented by treating hypoxia. Thus, this study aimed to determine whether daily short-duration reoxygenation at sea level attenuates pulmonary hypertension under high-altitude hypoxia. To this end, a simulated 5,000-m hypoxia rat model was used to evaluate the effect of short-duration reoxygenation. Results show that intermittent, not continuous, short-duration reoxygenation effectively attenuates hypoxia-induced pulmonary hypertension. The mechanisms underlining the protective effects involved that intermittent, short-duration reoxygenation prevented functional and structural remodeling of pulmonary arteries and proliferation, migration, and phenotypic conversion of pulmonary artery smooth muscle cells under hypoxia. The specific genes or potential molecular pathways responsible for mediating the protective effects were also characterised by RNA sequencing.This study is novel in revealing a new potential method in preventing high-altitude pulmonary hypertension. It gives insights into the selection and optimisation of oxygen supply schemes in high-altitude areas.
-
08 GSE162239 对肺动脉高压(PAH)患者与健康志愿者的血清AHR激动剂活性进行比较,同时检测Sprague-Dawley大鼠在正常氧(Normoxia)和SU5416联合缺氧(Sugen-Hypoxia)处理下,野生型(WT)与Ahr-/-基因型在第0天和第4天的总肺组织及内皮细胞的mRNA表达谱,比较不同处理条件与基因型组合下的转录组差异。
设计对肺动脉高压(PAH)患者与健康志愿者的血清AHR激动剂活性进行比较,同时检测Sprague-Dawley大鼠在正常氧(Normoxia)和SU5416联合缺氧(Sugen-Hypoxia)处理下,野生型(WT)与Ahr-/-基因型在第0天和第4天的总肺组织及内皮细胞的mRNA表达谱,比较不同处理条件与基因型组合下的转录组差异。
摘要Pulmonary arterial hypertension (PAH) is a devastating disease characterized by arteriopathy in the small to medium-sized distal pulmonary arteries, often accompanied by infiltration of inflammatory cells. Aryl hydrocarbon receptor (AHR), a nuclear receptor/transcription factor, detoxifies xenobiotics and regulates the differentiation and function of various immune cells. However, the role of AHR in the pathogenesis of PAH is largely unknown. Here, we explore the role of AHR in the pathogenesis of PAH. AHR agonistic activity in serum was significantly higher in PAH patients than in healthy volunteer and was associated with poor prognosis of PAH. Sprague-Dawley (SD) rats treated with the potent endogenous AHR agonist, 6-formylindolo[3,2-b]carbazole in combination with hypoxia develop severe pulmonary hypertension (PH) with plexiform-like lesions, whereas SD rats treated with the potent vascular endothelial growth factor receptor 2 inhibitors did not. Ahr-knockout (Ahr-/-) rats generated using the CRISPR/Cas9 system did not develop PH in the SU5416/hypoxia model. A diet containing Qing-Dai, a Chinese herbal drug, in combination with hypoxia led to development of PH in Ahr+/+ rats, but not in Ahr-/- rats. RNA-seq analysis, ChIP-seq analysis, immunohistochemical analysis, and bone marrow transplantation experiments shows that activation of several inflammatory signaling pathways were upregulated in endothelial cells and peripheral blood mononuclear cells, which led to infiltration of CD4+ IL-21+ T cells and MRC1+ macrophages into vascular lesions in an AHR-dependent manner. Taken together, AHR plays crucial roles in the development and progression of PAH and the AHR signaling pathway represents a promising novel therapeutic target for PAH
-
09 GSE183339 对MCT大鼠肺组织进行RNA测序,分组为Angiotensin 2处理组、TRV023处理组、Losartan处理组及PBS对照组,比较各处理组与对照组的基因表达差异。
设计对MCT大鼠肺组织进行RNA测序,分组为Angiotensin 2处理组、TRV023处理组、Losartan处理组及PBS对照组,比较各处理组与对照组的基因表达差异。
摘要We report the application of RNA sequencing in lung tissues of MCT rats, that were treated with Angiotensin 2 or TRV023 or Losartan to study their effects on Pulmonary hypertension. We received FPKM data of each gene from each group of MCT rats. The gene expression of the study MCT rats were normalized to control MCT rat. The differentially expressed genes in Angiotensin 2 and TRV023 treated MCT rats, confirmed that like Angiotensin 2, TRV023 is also involved in vascular remodelling and lead to worsening of pulmonary hypertension.
-
10 GSE271297 对肺动脉高压(PAH)患者及健康对照的肠道微生物群进行分析,并将肺动脉高压患者或MCT-PAH大鼠的粪菌移植至正常大鼠,同时将健康大鼠粪菌移植至MCT-PAH大鼠,采集肺组织进行RNA测序,比较MCT-PAH大鼠与FMT处理大鼠的转录组差异。
设计对肺动脉高压(PAH)患者及健康对照的肠道微生物群进行分析,并将肺动脉高压患者或MCT-PAH大鼠的粪菌移植至正常大鼠,同时将健康大鼠粪菌移植至MCT-PAH大鼠,采集肺组织进行RNA测序,比较MCT-PAH大鼠与FMT处理大鼠的转录组差异。
摘要Rationale: Recent studies suggest a potential link between gut bacterial microbiota dysbiosis and PAH, but the exact role of gut microbial communities, including bacteria, archaea, and fungi, in PAH remains unclear. Objectives: To investigate the role of gut microbiota dysbiosis in idiopathic pulmonary arterial hypertension (IPAH) and to assess the therapeutic potential of fecal microbiota transplantation (FMT) in modulating PAH progression. Methods: Using shotgun metagenomics, we analyzed gut microbial communities in IPAH patients and healthy controls. FMT was performed to transfer gut microbiota from IPAH patients or MCT-PAH rats to normal rats and from healthy rats to MCT-PAH rats. Hemodynamic measurements, echocardiography, histological examination, metabolomic and RNA-seq analysis were conducted to evaluate the effects of FMT on PAH phenotypes. Measurements and Main Results: Gut microbiota analysis revealed significant alterations in the bacterial, archaeal, and fungal communities in IPAH patients compared to healthy controls. FMT from IPAH patients induced PAH phenotypes in recipient rats. Conversely, FMT from healthy rats to IPAH rats significantly ameliorated PAH symptoms, restored gut microbiota composition, and normalized serum metabolite profiles. Specific microbial species were identified with high diagnostic potential for IPAH, improving predictive performance beyond individual or combined microbial communities. Conclusions: This study establishes a causal link between gut microbiota dysbiosis and IPAH and demonstrates the therapeutic potential of FMT in reversing PAH phenotypes. The findings highlight the critical role of bacterial, archaeal, and fungal communities in PAH pathogenesis and suggest that modulation of the gut microbiome could be a promising treatment strategy for PAH.
-
11 GSE8078 将Dahl Salt-Sensitive大鼠分为5组:normoxia/vehicle(Norm)、hypoxia/vehicle(H)、hypoxia/SU5416(H-SU)、hypoxia/Sorafenib(H-Sor)和hypoxia/SU5416/Sorafenib(H-SU-Sor)。除Norm组外,所有大鼠均置于FiO2为10%的低氧舱中,H组单次注射SU5416(20 mg/kg)并每日灌胃Sorafenib(2.5 mg/kg),H-SU组同时接受SU5416和Sorafenib处理。3.5周后通过开放胸腔导管化测量肺血管和右心室压力,采集肺组织进行微阵列分析,比较H、H-SU组与Norm组的基因表达差异,以及H-SU与H-SU-Sor组间的差异。H组(n=4)和H-SU组(n=3)肺组织样本分别与Norm组(n=4)比较,H-SU-Sor组(n=4)与H-SU组比较。
设计将Dahl Salt-Sensitive大鼠分为5组:normoxia/vehicle(Norm)、hypoxia/vehicle(H)、hypoxia/SU5416(H-SU)、hypoxia/Sorafenib(H-Sor)和hypoxia/SU5416/Sorafenib(H-SU-Sor)。除Norm组外,所有大鼠均置于FiO2为10%的低氧舱中,H组单次注射SU5416(20 mg/kg)并每日灌胃Sorafenib(2.5 mg/kg),H-SU组同时接受SU5416和Sorafenib处理。3.5周后通过开放胸腔导管化测量肺血管和右心室压力,采集肺组织进行微阵列分析,比较H、H-SU组与Norm组的基因表达差异,以及H-SU与H-SU-Sor组间的差异。H组(n=4)和H-SU组(n=3)肺组织样本分别与Norm组(n=4)比较,H-SU-Sor组(n=4)与H-SU组比较。
摘要Pulmonary hypertension (PH) and cancer pathophysiology share common signal transduction pathways leading to abnormal endothelial and smooth muscle cell interactions and angioproliferative vasculopathy. Sorafenib (Sor) a drug in clinical trials for cancer treatment, is an inhibitor of multiple kinases important in angiogenesis (Raf-1 kinase, VEGFR-2, VEGFR-3, PDGFR-beta). In this study, we assessed the efficacy of Sor as a potential therapy for PH, and hypothesized that Sor prevents the development of both a conventional and an augmented rodent model of PH. We performed studies in Dahl Salt-Sensitive rats (SS) exposed to hypoxia alone and in combination with the VEGFR-2 inhibitor, SU5416, known to induce a well-characterized augmented PH phenotype. Rats were, thus, divided into 5 groups: normoxia/vehicle (Norm), hypoxia/vehicle (H), hypoxia/ SU5416 (H-SU), hypoxia/Sorafenib (H-Sor) and hypoxia/ SU5416/ Sorafenib (H-SU-Sor). Except for the Norm group, all rats were maintained in a hypoxia chamber with a FiO2 of 10%. Rats received a single injection of SU5416 on Day 1 (20 mg/kg) and Sor solution was administered daily by gavage (2.5mg/kg). After 3.5 weeks, all rats were assessed by open chest catheterizations for pulmonary vascular and right ventricular pressures. Lung and heart tissue were harvested for histological and microarray analyses. Our results showed H-SU rats developed severe PH with changes in hemodynamic and histologic parameters when compared to Norm controls while rats exposed to H alone only displayed mildly elevated pressures compared with Norm. There was no significant change in pressures in the H-Sor or H-SU-Sor compared to Norm. Histopathology demonstrated a dramatic prevention of the PH phenotype in the H-SU-Sor rats with no significant remodeling compared with H-SU rats. Expression profiling data from H (n=4) and H-SU (n=3) rat lungs were compared to Norm (n=4) using normalization in R and SAM (δ>.639,) (minimum fold change >1.4). With false discovery rates (FDR) of 6.5% in hypoxia and 1.6% in H-SU, 1019 and 465 genes, respectively, were differentially-regulated compared to Norm. In addition, 38 genes were differentially expressed between H-SU and H-SU-Sor (n=4, FDR 6.7%) revealing a molecular signature with potentially novel target genes of Sor. Five differentially expressed genes (Tgfbeta3, C1qg, Nexn, Frzb, and Plaur) were examined by real-time RT-PCR and three were further validated by immunohistochemistry confirming the regulation on protein level. Based on the known pathways of hypoxic-induced PH and Sor, we further utilized immunohistochemistry to show the up-regulation of mediators of the MAPK cascade in the H and H-SU models of PH with subsequent, down-regulation by Sor. We therefore present Sor as a novel treatment for the development of severe PH and theorize that the MAPK cascade is a canonical pathway involved both in the development of PH and in the attenuation by Sor. Keywords: Drug Effect
-
12 GSE194067 对健康大鼠和单克隆内皮素诱导的肺动脉高压大鼠的肺组织进行转录组分析,分别采用载体雾化处理和SGC-CBP30雾化处理,比较不同处理条件下基因表达差异。
设计对健康大鼠和单克隆内皮素诱导的肺动脉高压大鼠的肺组织进行转录组分析,分别采用载体雾化处理和SGC-CBP30雾化处理,比较不同处理条件下基因表达差异。
摘要Pulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disease that culminates in right heart failure. Vascular pathology in PH is characterized by pulmonary vasoconstriction and progressive vascular remodeling processes that affects all layers of the vascular wall (intima, media and adventitia). Our objective was to profile and analyze the differential gene expression signatures between the cells isolated from normal and idiopathic PAH patients. We generated vascular cell-specific transcriptome profiles from the adventitial fibroblasts (PAAF) isolated ex vivo from the dissected human pulmonary arteries of normal donor and PAH lungs using paired-end RNA-sequencing.
-
13 GSE190203 对MCT诱导的肺动脉高压大鼠模型肺组织进行RNA测序,比较3,3-二甲基-1-丁醇处理组与未处理组的转录组差异。研究对象为Sprague Dawley大鼠,样本为肺组织,检测方式为RNA测序,处理条件包含MCT诱导和DMB干预,主要比较DMB处理组与未处理组的转录特征差异。
设计对MCT诱导的肺动脉高压大鼠模型肺组织进行RNA测序,比较3,3-二甲基-1-丁醇处理组与未处理组的转录组差异。研究对象为Sprague Dawley大鼠,样本为肺组织,检测方式为RNA测序,处理条件包含MCT诱导和DMB干预,主要比较DMB处理组与未处理组的转录特征差异。
摘要Trimethylamine N-oxide (TMAO), a metabolite derived from intestine microbial flora, enhances vascular inflammation in a variety of cardiovascular disease, and the bacterial communities associated with trimethylamine N-oxide (TMAO) metabolism is higher in pulmonary hypertension (PH) patients. The effects of TMAO on PH, however, has not been elucidated. In the present study, we found that circulating TMAO is elevated in intermediate to high-risk PH patients when compared to healthy control or low-risk PH patients. In monocrotaline-induced rat PH models, circulating TMAO is elevated; and reduction of TMAO using 3,3-dimethyl-1-butanol (DMB) significantly decreased right ventricle systolic pressure, pulmonary vascular muscularization in both monocrotaline-induced rat PH and hypoxia induced mice PH models. RNA sequencing of rat lungs on DMB revealed significant suppression of pathways involved in cytokine-cytokine receptor interaction, and cytokine and chemokine signaling. Protein-protein interaction analysis of the differentially expressed transcripts regulated by DMB showed 5 hub genes with a strong connectivity of proinflammatory cytokines and chemokines including Kng1, Cxcl1, Cxcl2, CxcL6 and Il6. In vivo, TMAO significantly increased the expression of Kng1, Cxcl1, Cxcl2, CxcL6 and Il6 in bone marrow derived macrophage. And TMAO-treated conditioned medium from macrophage increased the proliferation and migration of pulmonary artery smooth muscle cells; but TMAO treatment did not change the proliferation or migration of pulmonary artery smooth muscle cells. In conclusion, our study demonstrates that TMAO is increased in severe PH, and the reduction of TMAO using DMB reduces pulmonary vascular muscularization and alleviates PH via suppressing the macrophage production of chemokines and cytokines.
-
14 GSE215341 对肺动脉高压模型大鼠肺组织进行RNA测序,比较MCT处理组与对照组的转录组差异。采用Illumina NovaseqTM 6000平台对混池RNA构建的cDNA文库进行高通量测序,获取2×150 bp配对端读取数据,并通过Cutadapt软件过滤获得高质量清洁读取。
设计对肺动脉高压模型大鼠肺组织进行RNA测序,比较MCT处理组与对照组的转录组差异。采用Illumina NovaseqTM 6000平台对混池RNA构建的cDNA文库进行高通量测序,获取2×150 bp配对端读取数据,并通过Cutadapt软件过滤获得高质量清洁读取。
摘要Right heart failure results from advanced pulmonary hypertension (PH) and has a poor prognosis. There are few available treatments for right heart failure. Pulmonary artery remodeling, including changes in pulmonary artery endothelial cells to endothelial-mesenchymal cells, and aberrant fibroblast and pulmonary artery smooth muscle cell (PASMC) proliferation, are characteristics of the pathophysiological process of PH. As a result, the clinical situation requires novel PH diagnostic and treatment targets.
-
15 GSE42767 对Sprague-Dawley大鼠肺部原代内皮细胞进行基因表达分析,比较单硝酸甘油处理组与生理盐水对照组的差异。实验将8只8-10周龄大鼠分为两组,每组4只,分别接受60mg/kg单硝酸甘油或生理盐水注射,5天后直接从磁珠分选的肺组织中提取总RNA。采用Agilent微阵列平台检测,数据经背景校正、去趋势处理、log2转换和quantile归一化,使用Bioconductor limma包进行标准化处理。
设计对Sprague-Dawley大鼠肺部原代内皮细胞进行基因表达分析,比较单硝酸甘油处理组与生理盐水对照组的差异。实验将8只8-10周龄大鼠分为两组,每组4只,分别接受60mg/kg单硝酸甘油或生理盐水注射,5天后直接从磁珠分选的肺组织中提取总RNA。采用Agilent微阵列平台检测,数据经背景校正、去趋势处理、log2转换和quantile归一化,使用Bioconductor limma包进行标准化处理。
摘要Endothelial cell (EC) dysfunction plays a key role in the pathogenesis of pulmonary arterial hypertension (PAH). To avoid cell cultures and whole lung tissue samples, we have, for the first time, used CD31 antibody coated magnetic beads in conjunction with genome scale RNA expression microarrays to profile ECs in vivo at any stage of PAH. We hypothesized that targeting early stages of the disease would identify novel mediators of PAH and genes linked to bone morphogenetic protein receptor 2 (BMPR2) signaling.
-
16 GSE8132 将Dahl Salt-Sensitive大鼠分为5组:normoxia/vehicle(Norm)、hypoxia/vehicle(H)、hypoxia/SU5416(H-SU)、hypoxia/Sorafenib(H-Sor)和hypoxia/SU5416/Sorafenib(H-SU-Sor)。除Norm组外,所有组均置于FiO2为10%的低氧舱中饲养3.5周。H组单次注射SU5416(20 mg/kg)于第1天,H-Sor组每日灌胃Sorafenib(2.5 mg/kg)。采集肺组织进行基因表达检测,比较H、H-SU、H-SU-Sor组与Norm组的差异,同时分析H-SU与H-SU-Sor组间的基因表达变化。
设计将Dahl Salt-Sensitive大鼠分为5组:normoxia/vehicle(Norm)、hypoxia/vehicle(H)、hypoxia/SU5416(H-SU)、hypoxia/Sorafenib(H-Sor)和hypoxia/SU5416/Sorafenib(H-SU-Sor)。除Norm组外,所有组均置于FiO2为10%的低氧舱中饲养3.5周。H组单次注射SU5416(20 mg/kg)于第1天,H-Sor组每日灌胃Sorafenib(2.5 mg/kg)。采集肺组织进行基因表达检测,比较H、H-SU、H-SU-Sor组与Norm组的差异,同时分析H-SU与H-SU-Sor组间的基因表达变化。
摘要Pulmonary hypertension (PH) and cancer pathophysiology share common signal transduction pathways leading to abnormal endothelial and smooth muscle cell interactions and angioproliferative vasculopathy. Sorafenib (Sor) a drug in clinical trials for cancer treatment, is an inhibitor of multiple kinases important in angiogenesis (Raf-1 kinase, VEGFR-2, VEGFR-3, PDGFR-beta). In this study, we assessed the efficacy of Sor as a potential therapy for PH, and hypothesized that Sor prevents the development of both a conventional and an augmented rodent model of PH. We performed studies in Dahl Salt-Sensitive rats (SS) exposed to hypoxia alone and in combination with the VEGFR-2 inhibitor, SU5416, known to induce a well-characterized augmented PH phenotype. Rats were, thus, divided into 5 groups: normoxia/vehicle (Norm), hypoxia/vehicle (H), hypoxia/ SU5416 (H-SU), hypoxia/Sorafenib (H-Sor) and hypoxia/ SU5416/ Sorafenib (H-SU-Sor). Except for the Norm group, all rats were maintained in a hypoxia chamber with a FiO2 of 10%. Rats received a single injection of SU5416 on Day 1 (20 mg/kg) and Sor solution was administered daily by gavage (2.5mg/kg). After 3.5 weeks, all rats were assessed by open chest catheterizations for pulmonary vascular and right ventricular pressures. Lung and heart tissue were harvested for histological and microarray analyses. Our results showed H-SU rats developed severe PH with changes in hemodynamic and histologic parameters when compared to Norm controls while rats exposed to H alone only displayed mildly elevated pressures compared with Norm. There was no significant change in pressures in the H-Sor or H-SU-Sor compared to Norm. Histopathology demonstrated a dramatic prevention of the PH phenotype in the H-SU-Sor rats with no significant remodeling compared with H-SU rats. Expression profiling data from H (n=4) and H-SU (n=3) rat lungs were compared to Norm (n=4) using normalization in R and SAM (δ>.639,) (minimum fold change >1.4). With false discovery rates (FDR) of 6.5% in hypoxia and 1.6% in H-SU, 1019 and 465 genes, respectively, were differentially-regulated compared to Norm. In addition, 38 genes were differentially expressed between H-SU and H-SU-Sor (n=4, FDR 6.7%) revealing a molecular signature with potentially novel target genes of Sor. Five differentially expressed genes (Tgfbeta3, C1qg, Nexn, Frzb, and Plaur) were examined by real-time RT-PCR and three were further validated by immunohistochemistry confirming the regulation on protein level. Based on the known pathways of hypoxic-induced PH and Sor, we further utilized immunohistochemistry to show the up-regulation of mediators of the MAPK cascade in the H and H-SU models of PH with subsequent, down-regulation by Sor. We therefore present Sor as a novel treatment for the development of severe PH and theorize that the MAPK cascade is a canonical pathway involved both in the development of PH and in the attenuation by Sor. Keywords: Drug Effect
-
17 GSE162243 对肺动脉高压(PAH)模型大鼠的总肺组织进行RNA-Seq分析,比较Sprague-Dawley野生型(WT)与Ahr-/-基因型大鼠在SU5416/hypoxia处理56天后的mRNA表达谱差异。
设计对肺动脉高压(PAH)模型大鼠的总肺组织进行RNA-Seq分析,比较Sprague-Dawley野生型(WT)与Ahr-/-基因型大鼠在SU5416/hypoxia处理56天后的mRNA表达谱差异。
摘要Pulmonary arterial hypertension (PAH) is a devastating disease characterized by arteriopathy in the small to medium-sized distal pulmonary arteries, often accompanied by infiltration of inflammatory cells. Aryl hydrocarbon receptor (AHR), a nuclear receptor/transcription factor, detoxifies xenobiotics and regulates the differentiation and function of various immune cells. However, the role of AHR in the pathogenesis of PAH is largely unknown. Here, we explore the role of AHR in the pathogenesis of PAH. AHR agonistic activity in serum was significantly higher in PAH patients than in healthy volunteer and was associated with poor prognosis of PAH. Sprague-Dawley (SD) rats treated with the potent endogenous AHR agonist, 6-formylindolo[3,2-b]carbazole in combination with hypoxia develop severe pulmonary hypertension (PH) with plexiform-like lesions, whereas SD rats treated with the potent vascular endothelial growth factor receptor 2 inhibitors did not. Ahr-knockout (Ahr-/-) rats generated using the CRISPR/Cas9 system did not develop PH in the SU5416/hypoxia model. A diet containing Qing-Dai, a Chinese herbal drug, in combination with hypoxia led to development of PH in Ahr+/+ rats, but not in Ahr-/- rats. RNA-seq analysis, ChIP-seq analysis, immunohistochemical analysis, and bone marrow transplantation experiments shows that activation of several inflammatory signaling pathways were upregulated in endothelial cells and peripheral blood mononuclear cells, which led to infiltration of CD4+ IL-21+ T cells and MRC1+ macrophages into vascular lesions in an AHR-dependent manner. Taken together, AHR plays crucial roles in the development and progression of PAH and the AHR signaling pathway represents a promising novel therapeutic target for PAH
-
18 GSE16624 对照大鼠肺组织与主动脉结扎导致肺动脉高压及心力衰竭(CHF)的大鼠肺组织进行比较,采集肺组织样本,使用微阵列分析基因表达,时间点为手术后9周,样本量为6个。
设计对照大鼠肺组织与主动脉结扎导致肺动脉高压及心力衰竭(CHF)的大鼠肺组织进行比较,采集肺组织样本,使用微阵列分析基因表达,时间点为手术后9周,样本量为6个。
摘要Pulmonary hypertension is a frequent consequence of left heart disease and congestive heart failure (CHF) and causes extensive lung vascular remodelling which leads to right ventricular failure. Functional genomics underlying this structural remodelling are unknown but present potential targets for novel therapeutic strategies. We used microarrays to detail the gene expression underlying vascular remodeling in the pathogenesis of pulmonary hypertension and identified distinct classes of up-regulated genes during this process.
-
19 GSE252564 将雄性大鼠分为单次腹腔注射 60 mg/kg 单甲基肼(MCT)处理组与皮下注射等体积生理盐水对照组,采集肺组织进行 RNA 测序,比较两组间基因表达差异。
设计将雄性大鼠分为单次腹腔注射 60 mg/kg 单甲基肼(MCT)处理组与皮下注射等体积生理盐水对照组,采集肺组织进行 RNA 测序,比较两组间基因表达差异。
摘要To investigate the underlying mechanism of pulmonary hypertension, the model of monocrotaline (MCT)-treated pulmonary arterial hypertension (PAH) rats were constructed to detect the differentially expressed profile of genes in lung tissue of PAH rat.
-
20 GSE27393 HIV Tg rats exhibit pulmonary hypertension and pulmonary artery remodeling. In an effort to begin to understand cell signaling pathways which are altered in lungs from HIV transgenic rats, we used microarray analysis.
-
21 GSE328273 将成年雄性Sprague-Dawley大鼠建立MCT诱导的肺动脉高压模型,随机分为正常对照(NC)、PAH、PAH+sham及PAH+TCST四组。MCT注射后28天收集肺组织,PAH+sham组与PAH+TCST组进行RNA-seq分析(每组3个生物重复)。检测钙信号通路及转录组变化,比较TCST处理组与假手术组的差异。
设计将成年雄性Sprague-Dawley大鼠建立MCT诱导的肺动脉高压模型,随机分为正常对照(NC)、PAH、PAH+sham及PAH+TCST四组。MCT注射后28天收集肺组织,PAH+sham组与PAH+TCST组进行RNA-seq分析(每组3个生物重复)。检测钙信号通路及转录组变化,比较TCST处理组与假手术组的差异。
摘要Pulmonary arterial hypertension (PAH) is mostly induced by excessive proliferation of pulmonary arterial smooth muscle cells (PASMCs) with undefined mechanism. This study investigated the function and mechanism of transection of the cervical sympathetic trunk (TCST) on the progression of monocrotaline (MCT)-induced PAH in rats and explored the underlying mechanism.A rat model of PAH was established by MCT injection. We evaluated the restoration of pulmonary architecture and hemodynamic parameters following TCST. Transcriptome sequencing (RNA-seq) was performed to identify key regulatory genes and signaling pathways that are particularly correlated with PASMC proliferation. The identified genes and pathways were further validated in the PAH model.TCST significantly attenuated pulmonary vascular remodeling and improved hemodynamic condition, as evidenced by reduced mean pulmonary arterial pressure (mPAP), right ventricular systolic pressure (RVSP), and right ventricular hypertrophy index (RVHI) compared to the PAH+sham group. RNA-seq analysis revealed that TCST suppressed calcium signaling and cell proliferation pathways, with downregulated DEGs enriched in immune responses, inflammatory responses, and the calcium signaling pathway. Differential expression analysis showed downregulation of the calcium pathway genes Adra1d and Tacr1, as well as their transcriptional regulator Foxa3. Further qPCR experiments confirmed decreased levels of Adra1d, Tacr1, Plcb1, and Foxa3. ELISA confirmed the inhibited expression of inositol trisphosphate (IP3), which directly regulate intracellular calcium concentration.We explored the mechanism of TCST in ameliorating PAH by the suppression of the Foxa3/Adra1d-Tacr1 axis involved in calcium signaling, revealing a novel link between PAH and calcium-driven vascular remodeling, and a mechanistic basis for TCST as a potential therapeutic strategy for PAH.

课题合作 · 扫码加微信
bioinformaticsboy